<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Reprod Update</journal-id><journal-id journal-id-type="publisher-id">humupd</journal-id><journal-id journal-id-type="hwp">humupd</journal-id><journal-title-group><journal-title>Human Reproduction Update</journal-title></journal-title-group><issn pub-type="ppub">1355-4786</issn><issn pub-type="epub">1460-2369</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18805939</article-id><article-id pub-id-type="pmc">2639061</article-id><article-id pub-id-type="doi">10.1093/humupd/dmn040</article-id><article-id pub-id-type="publisher-id">dmn040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Functional genetic polymorphisms and female reproductive disorders: Part II&#x02014;endometriosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tempfer</surname><given-names>C.B.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="corresp" rid="cor1">5</xref></contrib><contrib contrib-type="author"><name><surname>Simoni</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Destenaves</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Fauser</surname><given-names>B.C.J.M.</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib></contrib-group><aff id="af1"><label>1</label><addr-line>Department of Obstetrics and Gynecology</addr-line>, <institution>Medical University</institution>, <addr-line>1090 Vienna</addr-line>, <country>Austria</country></aff><aff id="af2"><label>2</label><addr-line>Department of Medicine, Endocrinology and Metabolism</addr-line>, <institution>University of Modena and Reggio Emilia</institution>, <addr-line>I-41100 Modena</addr-line>, <country>Italy</country></aff><aff id="af3"><label>3</label><addr-line>Stratified Medicine Group, Merck Serono International S.A, 1202 Geneva</addr-line>, <country>Switzerland</country></aff><aff id="af4"><label>4</label><addr-line>Department of Reproductive Medicine and Gynecology</addr-line>, <institution>University Medical Center</institution>, <addr-line>3508 GA Utrecht</addr-line>, <country>The Netherlands</country></aff><author-notes><corresp id="cor1"><label>5</label>Correspondence address. E-mail: <email>clemens.tempfer@meduniwien.ac.at</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>9</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>9</month><year>2008</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="epub"/>. --><volume>15</volume><issue>1</issue><fpage>97</fpage><lpage>118</lpage><history><date date-type="received"><day>11</day><month>3</month><year>2008</year></date><date date-type="rev-recd"><day>1</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</copyright-statement><copyright-year>2009</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p>The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org</license-p></license></permissions><abstract><sec><title>BACKGROUND</title><p>Endometriosis has a strong genetic component, and numerous genetic studies have been reported.</p></sec><sec><title>METHODS</title><p>We have systematically reviewed these studies and included 114 in our final selection.</p></sec><sec><title>RESULTS</title><p>We found no consistent evidence linking endometriosis with specific polymorphisms in genes encoding inflammatory mediators, proteins involved in sex steroid metabolism, vascular function and tissue remodelling. Although a number of polymorphisms have been associated with endometriosis in selected populations, the associations have not been independently confirmed, either because only single studies were carried out on these markers/genes or because other studies reported no association. The most solid evidence linking specific polymorphisms to endometriosis came from studies investigating glutathione-<italic>S</italic>-transferase, a phase II detoxification enzyme. Carriage of the <italic>GSTT1</italic> null deletion variant showed consistent association with endometriosis with a 29% increased risk; however, it cannot be excluded that this result was due to publication bias, and this association should be independently confirmed in large-scale, well-designed case&#x02013;control studies.</p></sec><sec><title>CONCLUSIONS</title><p>The evidence of an association between genetic polymorphisms and endometriosis is weak. Carriage of the <italic>GSTT1</italic> null deletion may moderately increase the risk of this disease. We suggest that the methodology of association studies should be improved in order to identify and validate associations in endometriosis.</p></sec></abstract><kwd-group><kwd>endometriosis</kwd><kwd>female reproduction</kwd><kwd>genetic polymorphisms</kwd><kwd>detoxification</kwd><kwd>sex steroids</kwd></kwd-group></article-meta></front><body><sec sec-type="" id="s1"><title>Introduction</title><p>The association between genetic polymorphisms and clinical disease has long been recognized. For example, a relationship between blood group and gastrointestinal cancer was described in the 1950s (<xref ref-type="bibr" rid="DMN040C17">Billington, 1956</xref>). More recently, technological advances in molecular biology have fuelled the interest in molecular polymorphisms and their influence on the susceptibility and clinical presentation of diseases (<xref ref-type="bibr" rid="DMN040C109">Tempfer <italic>et al</italic>., 2004</xref>).</p><p>Many aspects of female reproductive function are strongly influenced by genetic factors, and numerous studies have attempted to identify susceptibility genes for disorders affecting female fertility such as polycystic ovary syndrome, endometriosis, fibroids, cancer (ovarian, vulvar, cervical), premature ovarian failure, recurrent pregnancy loss and pre-eclampsia (<xref ref-type="bibr" rid="DMN040C90">Levanat <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="DMN040C94">Modugno, 2004</xref>; <xref ref-type="bibr" rid="DMN040C30">Escobar-Morreale <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C36">Goswami and Conway, 2005</xref>; <xref ref-type="bibr" rid="DMN040C110">Tempfer <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C34">Ferreira <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="DMN040C87">Layman, 2006</xref>). For many of these conditions, the search for genetic disease markers is ongoing, and no strong candidate has yet emerged.</p><p>Endometriosis is characterized by the presence and growth of endometrial cells outside the uterus, which impair fertility (<xref ref-type="bibr" rid="DMN040C130">Wenzl <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C43">Halis and Arici, 2004</xref>), and the disease has a strong genetic component (<xref ref-type="bibr" rid="DMN040C112">Treloar <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="DMN040C17a">Bischoff and Simpson, 2004</xref>; <xref ref-type="bibr" rid="DMN040C124">Vigano <italic>et al</italic>., 2007</xref>). In a study of the genetic influence on endometriosis risk in an Australian twin sample, for example, the risk ratio of affected versus population prevalence was 3.58 for monozygotic twins and 2.32 for dizygotic twins (<xref ref-type="bibr" rid="DMN040C112">Treloar <italic>et al</italic>., 1999</xref>). Clarifying the genetic etiology of endometriosis would have implications for diagnosis, identification of individuals at risk and the development of targeted therapeutics.</p><p>This disorder has been the focus of a large number of association studies investigating a wide variety of polymorphisms. Previous reviews assessed the possible role of specific polymorphisms or groups of polymorphisms, indicating that the number of robust associations may be low (<xref ref-type="bibr" rid="DMN040C31">Falconer <italic>et al</italic>., 2007</xref>). Some have even challenged the evidence for endometriosis having a genetic background (<xref ref-type="bibr" rid="DMN040C26">Di and Guo, 2007</xref>).</p><p>In this review, we assess evidence for the role of genetic polymorphisms in endometriosis. We present a systematic review of the published literature across all polymorphisms investigated in relation to endometriosis. We have evaluated the reliability and strength of the evidence for each of the 114 selected studies and discuss methods for improving association studies. However, to enable proper evalauation of the studies, we first explore the methodology of molecular association.</p></sec><sec sec-type="" id="s2"><title>Genetic association studies of polymorphisms</title><p>The genetic basis of disease may be elucidated in different ways. One approach is to scan across the genome to identify markers/genes of interest; a second approach is to investigate specific &#x02018;candidate&#x02019; genes. We discuss these approaches below, and provide examples of such studies in endometriosis.</p><p>Genome-wide linkage analysis using affected sibling-pairs has been applied to endometriosis by Australian, British and Icelandic groups (<xref ref-type="bibr" rid="DMN040C107">Stefansson <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="DMN040C113">Treloar <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="DMN040C73">Kennedy <italic>et al</italic>., 2001</xref>). These studies aim to find chromosomal regions shared by related individuals harbouring disease-predisposing genes. In these linkage studies, which are conceptually different from case&#x02013;control studies in unrelated individuals, a possible informative locus on chromosome 10q has been reported (<xref ref-type="bibr" rid="DMN040C113">Treloar <italic>et al</italic>., 2000</xref>). In addition, in a separate linkage analysis of families with three or more affected members, <xref ref-type="bibr" rid="DMN040C143">Zondervan <italic>et al</italic>. (2007</xref>) suggested that there may be one or more high-penetrance susceptibility loci for endometriosis on chromosome 7. A dominant mode of inheritance with reduced penetrance and a recessive mode of inheritance with high penetrance have been suggested for these potential genetic variants. To our knowledge, genome-wide genetic association studies on unrelated individuals have not been carried out.</p><p>Genetic case&#x02013;control studies identify markers/genes that are associated with a trait of interest, such as a given disease. Genetic association studies do not, however, prove an etiological link between the polymorphism and/or the gene in question and the investigated trait. Once identified, the association of a specific genetic marker within a candidate gene with the trait should be investigated further. Specifically, it has to be clarified, whether the allele of interest has a direct biological effect or whether the association is based on biological effects downstream of the allele, which are in linkage disequilibrium. Since linkage disequilibrium may vary in different populations, this is an important source of inconsistency.</p><p>A particular problem in interpreting the results from genetic association studies in endometriosis is linked to the fact that this is not a monogenic trait but a complex trait. Therefore, various genetic factors can be expected to have an effect with an additional level of variation regarding the individual effect sizes. Especially small effect sizes may be easily missed in individual studies with small sample sizes. Common methodological problems in genetic association studies include low sample size, chance findings, multiple comparisons and subsequent type I error inflation, different ethnic backgrounds of the study subjects, varying disease definitions and inclusion/exclusion criteria and ascertainment bias. To help overcome these methodological problems, <xref ref-type="bibr" rid="DMN040C142">Zondervan <italic>et al</italic>. (2002</xref>) proposed the following criteria for case&#x02013;control studies to identify an association between genetic polymorphisms and endometriosis: (i) use newly diagnosed, i.e. incident, cases with endometriosis, (ii) collect information predating symptoms and (iii) use at least one population-based female control group matched for unadjustable confounders and ideally also screened for pelvic symptoms. These criteria for high-quality case&#x02013;control studies, however, have not been fulfilled by the majority of the studies discussed in this review. Therefore, positive associations between genetic polymorphisms and endometriosis have to be interpreted with caution.</p><p>Ethnic background is an important source of variation. As illustrated by this review, genetic associations are often inconsistent across ethnic barriers, which may be due to different frequencies of polymorphic alleles as well as gene&#x02013;gene interactions. In this respect, a genetic association, although valid in a specific ethnic population, may not be relevant for individuals of another ethnicity. This has to be acknowledged when judging the external validity of any genetic association study.</p><p>Some of these methodological problems can be overcome&#x02014;at least in part&#x02014;by summarizing data from individual studies in the form of a meta-analysis. This tool has been increasingly used to confirm or rule out associations. Applying meta-analysis can be generally expected to confirm only a fraction of associations previously reported in individual small studies. Also, a strong association in individual studies with a <italic>P</italic>-value &#x0003c;0.001 has been reported to be a good predictor of confirmation in a meta-analysis (<xref ref-type="bibr" rid="DMN040C91">Lohmueller <italic>et al</italic>., 2003</xref>).</p><p>In this review, we have assessed the quality of evidence for every group of polymorphisms investigated in endometriosis association studies according to the agreement between studies, the presence or absence of meta-analyses and the strength of the association.</p></sec><sec sec-type="" id="s3"><title>Systematic review search criteria</title><p>We systematically searched the PubMed and EMBASE databases for gene association studies published up to the end of August 2007 using the term &#x02018;endometriosis&#x02019; combined with &#x02018;polymorphism OR polymorphisms&#x02019; or &#x02018;mutation OR mutations&#x02019;. The search was not limited by language of publication. Translations of non-English papers were not obtained. The principle author (C.B.T.) selected relevant studies using the following criteria: all studies investigating polymorphic genetic variants with cases, i.e. women with a clinical and/or surgical diagnosis of endometriosis irrespective of disease stage, and with controls, i.e. women irrespective of definition of controls, listing absolute numbers of the respective genotype distributions. The interpretation of the consistency of an association with endometriosis always refers to a specific polymorphism and not to any investigated polymorphism in a specific gene.</p></sec><sec sec-type="" id="s4"><title>Results</title><p>The search for endometriosis susceptibility polymorphisms was focused mainly on genes involved in inflammation, sex steroid regulation, metabolism, biosynthesis, detoxification, vascular function and tissue remodelling.</p><sec id="s4a"><title>Genes of inflammatory mediators</title><p>It is widely accepted that endometriosis is an inflammatory process, associated with altered immune cell function, immune cell numbers, and elevated levels of inflammatory cytokines (<xref ref-type="bibr" rid="DMN040C1">Agic <italic>et al</italic>., 2006</xref>). This observation has led researchers to investigate the effects of polymorphisms in genes encoding cytokines and other molecules involved in inflammation (see Table&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>).</p><table-wrap id="DMN040TB1" position="float"><label>Table I</label><caption><p>Polymorphisms of genes encoding inflammatory mediators, which have been investigated for their role in endometriosis</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene (locus, protein name and its function)</th><th align="left" colspan="2" rowspan="1">Variant<hr/></th><th align="left" colspan="2" rowspan="1">Association with susceptibility<hr/></th><th align="left" rowspan="1" colspan="1">Phenotype<break/></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Name</th><th align="left" rowspan="1" colspan="1">dbSNP ID</th><th align="left" rowspan="1" colspan="1">Positive (number of cases, number of controls)</th><th align="left" rowspan="1" colspan="1">Negative (number of cases, number of controls)</th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>CCL5</italic> [17q11.2-q12, chemokine (C&#x02013;C motif) ligand 5 (RANTES): chemokine]</td><td rowspan="1" colspan="1">&#x02212;403G/A</td><td rowspan="1" colspan="1">rs2107538</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (63, 36 or 110) (<xref ref-type="bibr" rid="DMN040C2">Antinolo <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;28C/G</td><td rowspan="1" colspan="1">rs2280788</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (63, 36 or 110) (<xref ref-type="bibr" rid="DMN040C2">Antinolo <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CCR2</italic> (3p21.31, monocyte chemotactic protein 1 receptor: chemokine receptor)</td><td rowspan="1" colspan="1">p.V64I</td><td rowspan="1" colspan="1">rs1799864</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (63, 36 or 110) (<xref ref-type="bibr" rid="DMN040C3">Antinolo <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CCR5</italic> (3p21.31, chemokine (C&#x02013;C motif) receptor 5: chemokine receptor)</td><td rowspan="1" colspan="1">Delta32 (32 bp deletion)</td><td rowspan="1" colspan="1">rs333</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (63, 36 or 110) (<xref ref-type="bibr" rid="DMN040C3">Antinolo <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CDH1</italic> (16q22.1, epithelial cadherin 1: adhesion molecule)</td><td rowspan="1" colspan="1">PmlI RFLP (3&#x02032;-UTR C/T)</td><td rowspan="1" colspan="1">rs1801026</td><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C56">Hsieh <italic>et al</italic>., 2005c</xref>)<break/>Chinese women (152, 189) (<xref ref-type="bibr" rid="DMN040C106">Shan <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;160C/A</td><td rowspan="1" colspan="1">rs1620</td><td rowspan="1" colspan="1">Chinese women: &#x02212;160A &#x02212;347GA haplotype. (152, 189) (<xref ref-type="bibr" rid="DMN040C106">Shan <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;347G/GA</td><td rowspan="1" colspan="1">rs5030625</td><td rowspan="1" colspan="1">Chinese women: &#x02212;160A &#x02212;347GA haplotype. (152, 189) (<xref ref-type="bibr" rid="DMN040C106">Shan <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CDKN1A</italic> (6p21.2, cyclin-dependent kinase inhibitor 1A (p21): regulation of cell cycle)</td><td rowspan="1" colspan="1">p.S31R</td><td rowspan="1" colspan="1">rs1801270</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (102, 119) (<xref ref-type="bibr" rid="DMN040C47">Hsieh <italic>et al</italic>., 2001c</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CTLA4</italic> (2q33, cytotoxic T lymphocyte antigen-4: T-cell ligand)</td><td rowspan="1" colspan="1">49A/G</td><td rowspan="1" colspan="1">rs231775</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Italian women (143, 165) (<xref ref-type="bibr" rid="DMN040C123">Vigano <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">CT60A/G</td><td rowspan="1" colspan="1">rs3087243</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Italian women (146, 153) (<xref ref-type="bibr" rid="DMN040C123">Vigano <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>EGFR</italic> (7p12, epidermal growth factor receptor: regulates cell growth and differentiation)</td><td rowspan="1" colspan="1">2073A/T</td><td rowspan="1" colspan="1">rs17337023</td><td rowspan="1" colspan="1">Taiwanese women (122, 139) (<xref ref-type="bibr" rid="DMN040C58">Hsieh <italic>et al</italic>., 2005e</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>FAS</italic> (10q24.1, FAS: mediates apoptosis)</td><td rowspan="1" colspan="1">&#x02212;1377G/A</td><td rowspan="1" colspan="1">rs2234767</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (78, 57 or 108) (<xref ref-type="bibr" rid="DMN040C32">Fernandez <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;670A/G</td><td rowspan="1" colspan="1">rs1800682</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (78, 57 or 108) (<xref ref-type="bibr" rid="DMN040C32">Fernandez <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>FASLG</italic> (1q23, FAS ligand: mediates apoptosis)</td><td rowspan="1" colspan="1">&#x02212;844C/T</td><td rowspan="1" colspan="1">rs763110</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Spanish women (78, 57 or 108) (<xref ref-type="bibr" rid="DMN040C32">Fernandez <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>HLA-A</italic> (6p21.3, human leukocyte antigen-A: major histocompatibility I protein)</td><td rowspan="1" colspan="1">HLA-A</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Chinese women (40, 50) (<xref ref-type="bibr" rid="DMN040C125">Wang <italic>et al</italic>., 2001</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>HLA-B</italic> (6p21.3, human leukocyte antigen-B: major histocompatibility I protein)</td><td rowspan="1" colspan="1">HLA-B</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Chinese women: HLA-B46, HLA-B48 alleles (40, 50) (<xref ref-type="bibr" rid="DMN040C125">Wang <italic>et al</italic>., 2001</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>HLA-DPB1</italic> (6p21.3, human leukocyte antigen DP &#x003b2;1: major histocompatibility II protein)</td><td rowspan="1" colspan="1">HLA-DPB1*01-*03, *0401-*0402, *05, *06, *08-*11, *13-*19</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (83, 222) (<xref ref-type="bibr" rid="DMN040C67">Ishii <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>HLA-DQB1</italic> (6p21.3, human leukocyte antigen DQ &#x003b2;1: major histocompatibility II protein)</td><td rowspan="1" colspan="1">HLA-DQB1*0201, *0301-*0303, *0401-*0402, *0501-*0503, *0601-*0604</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women: HLA-DQB1*0301 allele (83, 222 or 117) (<xref ref-type="bibr" rid="DMN040C67">Ishii <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>HLA-DRB1</italic> (6p21.3, human leukocyte antigen DR &#x003b2;1: major histocompatibility II protein)</td><td rowspan="1" colspan="1">HLA-DRB1*0101, *0301, *0401-*0408, *0410, *0701, *0801-*0803, *09, *10, *1101, *1104, *1201-*1202, *1301-*1302, *1401, *1402, *1404, *1405, *1501, *1502, *1602 (+ *0102, *0103, *0302, *0804, *1602, *1305 in Japanese study) (+ *1111, *1339, *1406, *1407, *1412 in Korean study)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women:<break/>HLA-DRB1*1403 (83, 222) (<xref ref-type="bibr" rid="DMN040C66">Ishii <italic>et al</italic>., 2002</xref>)</td><td rowspan="1" colspan="1">Chinese women (only looking at HLA-DRB1*1501 &#x00026; *1502) (40, 50) (<xref ref-type="bibr" rid="DMN040C126">Wang <italic>et al</italic>., 2002</xref>)<break/>Korean women (100, 800 or 108) (<xref ref-type="bibr" rid="DMN040C131">Whang <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>ICAM1</italic> (19p13.3-p13.2, intercellular adhesion molecule-1: adhesion molecule)</td><td rowspan="1" colspan="1">p.G241R</td><td rowspan="1" colspan="1">rs1799968</td><td rowspan="1" colspan="1">Caucasian women (180, 175) (<xref ref-type="bibr" rid="DMN040C122">Vigano <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1">Japanese women (126, 172) (<xref ref-type="bibr" rid="DMN040C138">Yamashita <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1">Caucasian women; disease severity (<xref ref-type="bibr" rid="DMN040C122">Vigano <italic>et al</italic>., 2003</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.K469E</td><td rowspan="1" colspan="1">rs5498</td><td rowspan="1" colspan="1">Japanese women. Association only seen in combination with IL-6 -634G (202, 236) (<xref ref-type="bibr" rid="DMN040C82">Kitawaki <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1">Caucasian women (180, 175) (<xref ref-type="bibr" rid="DMN040C122">Vigano <italic>et al</italic>., 2003</xref>)<break/>Japanese women (126, 172) (<xref ref-type="bibr" rid="DMN040C138">Yamashita <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IFNG</italic> (12q14, interferon-&#x003b3;: cytokine)</td><td rowspan="1" colspan="1">CA repeat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (185, 176) (<xref ref-type="bibr" rid="DMN040C81">Kitawaki <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IGF2</italic> (11p15.5, insulin-like growth factor II: cytokine)</td><td rowspan="1" colspan="1">ApaI RFLP (17 200G/A)</td><td rowspan="1" colspan="1">rs680</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (120, 103) (<xref ref-type="bibr" rid="DMN040C52">Hsieh <italic>et al</italic>., 2004c</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL4</italic> (5q31.1, interleukin-4: cytokine)</td><td rowspan="1" colspan="1">&#x02212;590C/T</td><td rowspan="1" colspan="1">rs2243250</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (120, 106) (<xref ref-type="bibr" rid="DMN040C48">Hsieh <italic>et al</italic>., 2002</xref>)<break/>Japanese women (185, 176) (<xref ref-type="bibr" rid="DMN040C81">Kitawaki <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">70 bp VNTR (intron 3)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (120, 106) (<xref ref-type="bibr" rid="DMN040C48">Hsieh <italic>et al</italic>., 2002</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL6</italic> (7p21, interleukin-6: cytokine)</td><td rowspan="1" colspan="1">&#x02212;174G/C</td><td rowspan="1" colspan="1">rs1800795</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women (70, 202) (<xref ref-type="bibr" rid="DMN040C88">Lee <italic>et al</italic>., 2002</xref>)<break/>Austrian women (94, 70) (<xref ref-type="bibr" rid="DMN040C135">Wieser <italic>et al</italic>., 2003a</xref>)<break/>South Indian women (232, 210) (<xref ref-type="bibr" rid="DMN040C15">Bhanoori <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;634C/G (&#x02212;572C/G)</td><td rowspan="1" colspan="1">rs1800796</td><td rowspan="1" colspan="1">Japanese women. Association only seen in combination with ICAM1 p.469E/E genotype (202, 236) (<xref ref-type="bibr" rid="DMN040C82">Kitawaki <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL10</italic> (1q31-q32, interleukin-10: cytokine)</td><td rowspan="1" colspan="1">&#x02212;1082G/A</td><td rowspan="1" colspan="1">rs1800896</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (196, 160) (<xref ref-type="bibr" rid="DMN040C80">Kitawaki <italic>et al</italic>., 2002</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;627A/C <break/>(&#x02212;592C/A)</td><td rowspan="1" colspan="1">rs1800872</td><td rowspan="1" colspan="1">Taiwanese women (130, 133) (<xref ref-type="bibr" rid="DMN040C49">Hsieh <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1">Japanese women (196, 160) (<xref ref-type="bibr" rid="DMN040C80">Kitawaki <italic>et al</italic>., 2002</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL18</italic> (11q22.2-q22.3, interleukin-18: cytokine)</td><td rowspan="1" colspan="1">105A/C</td><td rowspan="1" colspan="1">rs549908</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C55">Hsieh <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL1B</italic> (2q14, interleukin-1&#x003b2;: cytokine)</td><td rowspan="1" colspan="1">&#x02212;511C/T</td><td rowspan="1" colspan="1">rs16 944</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (120, 103) (<xref ref-type="bibr" rid="DMN040C45">Hsieh <italic>et al</italic>., 2001a</xref>)<break/>Chinese women (138, 100) (<xref ref-type="bibr" rid="DMN040C129">Wen <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3953C/T</td><td rowspan="1" colspan="1">rs1143634</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Austrian women (92, 69) (<xref ref-type="bibr" rid="DMN040C136">Wieser <italic>et al</italic>., 2003b</xref>)<break/>Taiwanese women (120, 103) (<xref ref-type="bibr" rid="DMN040C45">Hsieh <italic>et al</italic>., 2001a</xref>)<break/>Chinese women (138, 100) (<xref ref-type="bibr" rid="DMN040C129">Wen <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL1R1</italic> (2q11.2, interleukin-1 receptor 1: cytokine receptor)</td><td rowspan="1" colspan="1">PstI RFLP</td><td rowspan="1" colspan="1">rs2041748</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Brazilian women (109, 114) (<xref ref-type="bibr" rid="DMN040C22">D&#x02019;Amora <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">BsrBI RFLP</td><td rowspan="1" colspan="1">No dbSNP ID</td><td rowspan="1" colspan="1">Brazilian women (109, 114) (<xref ref-type="bibr" rid="DMN040C22">D&#x02019;Amora <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL2RB</italic> (22q13.1, interleukin-2 receptor &#x003b2;: cytokine receptor)</td><td rowspan="1" colspan="1">881T/C</td><td rowspan="1" colspan="1">rs228953</td><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C55">Hsieh <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL1RN</italic> (2q14.2, interleukin-1R antagonist: cytokine)</td><td rowspan="1" colspan="1">86 bp VNTR (intron 2)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Chinese women (138, 100) (<xref ref-type="bibr" rid="DMN040C129">Wen <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1">Taiwanese women (120, 103) (<xref ref-type="bibr" rid="DMN040C45">Hsieh <italic>et al</italic>., 2001a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IL12RB1</italic> (19p13.1, interleukin-12 receptor &#x003b2;: cytokine receptor)</td><td rowspan="1" colspan="1">p.G378R</td><td rowspan="1" colspan="1">rs401502</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C55">Hsieh <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>NOS3</italic> (7q36, endothelial nitric oxide synthase: catalyses synthesis of nitric oxide, a pro-inflammatory molecule)</td><td rowspan="1" colspan="1">p.E298D</td><td rowspan="1" colspan="1">rs1799983</td><td rowspan="1" colspan="1">Caucasian women in Greek population (94, 60) (<xref ref-type="bibr" rid="DMN040C139">Zervou <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TGFB1</italic> (19q13.1, transforming growth factor &#x003b2;1: cytokine)</td><td rowspan="1" colspan="1">&#x02212;509C/T</td><td rowspan="1" colspan="1">rs1800469</td><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C59">Hsieh <italic>et al</italic>., 2005f</xref>)</td><td rowspan="1" colspan="1">Dutch women (72, 95 or 93) (<xref ref-type="bibr" rid="DMN040C119">van Kaam <italic>et al</italic>., 2007a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TNF</italic> (6p21.3, tumour necrosis factor &#x003b1;: cytokine)</td><td rowspan="1" colspan="1">&#x02212;1031T/C</td><td rowspan="1" colspan="1">rs1799964</td><td rowspan="1" colspan="1">Japanese women: &#x02212;1031T, &#x02212;863C, &#x02212;857C haplotype (123, 165) (<xref ref-type="bibr" rid="DMN040C111">Teramoto <italic>et al</italic>., 2004</xref>)<break/>Japanese women (130, 185) (<xref ref-type="bibr" rid="DMN040C6">Asghar <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women; disease severity (<xref ref-type="bibr" rid="DMN040C6">Asghar <italic>et al</italic>., 2004</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;863C/A</td><td rowspan="1" colspan="1">rs1800630</td><td rowspan="1" colspan="1">Japanese women: &#x02212;1031T, &#x02212;863C, &#x02212;857C haplotype (123, 165) (<xref ref-type="bibr" rid="DMN040C111">Teramoto <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;857C/T</td><td rowspan="1" colspan="1">rs1799724</td><td rowspan="1" colspan="1">Japanese women: &#x02212;1031T, &#x02212;863C, &#x02212;857C haplotype (123, 165) (<xref ref-type="bibr" rid="DMN040C111">Teramoto <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;308G/A</td><td rowspan="1" colspan="1">rs1800629</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (120, 106) (<xref ref-type="bibr" rid="DMN040C48">Hsieh <italic>et al</italic>., 2002</xref>) Korean women (70, 202) (<xref ref-type="bibr" rid="DMN040C88">Lee <italic>et al</italic>., 2002</xref>)<break/>Austrian women (92, 69) (<xref ref-type="bibr" rid="DMN040C132">Wieser <italic>et al</italic>., 2002a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;238G/A</td><td rowspan="1" colspan="1">rs361525</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women (70, 202) (<xref ref-type="bibr" rid="DMN040C88">Lee <italic>et al</italic>., 2002</xref>)<break/>Austrian women (92, 69) (<xref ref-type="bibr" rid="DMN040C132">Wieser <italic>et al</italic>., 2002a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs1800750, rs3093661, rs1800610, rs3093662, rs4645843, rs3093664, rs3091257</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Australian women (958, 959) (<xref ref-type="bibr" rid="DMN040C141">Zhao <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TNF</italic> (6p21.3, tumour necrosis factor &#x003b2; (Lymphotoxin-alpha LTA): cytokine)</td><td rowspan="1" colspan="1">Intron 1+252A/G (A1069G)</td><td rowspan="1" colspan="1">rs909253</td><td rowspan="1" colspan="1">Chinese women (82, 80) (<xref ref-type="bibr" rid="DMN040C93">Luo <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs2857602, rs2844486, rs3131637, rs2844484, rs2844483, rs4647191, rs2844482, rs2071590, rs1800683, rs2239704, rs909253, rs2857713, rs3093543, rs1041981</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Australian women (958, 959)<break/>(<xref ref-type="bibr" rid="DMN040C141">Zhao <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TNFRSF1B</italic> (1p36.3-p36.2, tumour necrosis factor receptor 2: cytokine receptor)</td><td rowspan="1" colspan="1">p.M196R</td><td rowspan="1" colspan="1">rs1061622</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (123, 165) (<xref ref-type="bibr" rid="DMN040C111">Teramoto <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TP53</italic> (17p13.1, tumour protein p53: regulation of cell cycle)</td><td rowspan="1" colspan="1">p.R72P</td><td rowspan="1" colspan="1">rs1042522</td><td rowspan="1" colspan="1">Chinese women (118, 140) (<xref ref-type="bibr" rid="DMN040C19">Chang <italic>et al</italic>., 2002</xref>)<break/>Taiwanese women (148, 150) (<xref ref-type="bibr" rid="DMN040C60">Hsieh and Lin, 2006</xref>)</td><td rowspan="1" colspan="1">Japanese women (105, 180 neonates) (<xref ref-type="bibr" rid="DMN040C98">Omori <italic>et al</italic>., 2004</xref>)<break/>Italian women (104, 88) (<xref ref-type="bibr" rid="DMN040C121">Vietri <italic>et al</italic>., 2007</xref>)<break/>Italian women (151, 153) (<xref ref-type="bibr" rid="DMN040C85">Lattuada <italic>et al</italic>., 2004b</xref>)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Genes are grouped alphabetically, and studies showing positive or negative associations of these genes with disease susceptibility and/or positive associations with phenotype are presented. RFLP, restriction fragment-length polymorphism; VNTR, variable number of tandem repeats.</p></fn></table-wrap-foot></table-wrap><sec id="s4a1"><title>Cytokines</title><p>In Taiwanese women, the &#x02212;509C/T promoter polymorphism in the transforming growth factor (TGF) &#x003b2;1 gene (<xref ref-type="bibr" rid="DMN040C59">Hsieh <italic>et al</italic>., 2005f</xref>), the 881T/C polymorphism in the interleukin (IL)-2 receptor &#x003b2; gene (<xref ref-type="bibr" rid="DMN040C55">Hsieh <italic>et al</italic>., 2005b</xref>) and the &#x02212;627A/C promoter polymorphism in the IL-10 gene (<xref ref-type="bibr" rid="DMN040C49">Hsieh <italic>et al</italic>., 2003</xref>) have all been associated to endometriosis susceptibility. Two polymorphisms in the promoter region of the IL-10 gene, &#x02212;1082G/A and &#x02212;592C/A [note that this is the same as the &#x02212;627A/C single-nucleotide polymorphism (SNP) studied by <xref ref-type="bibr" rid="DMN040C49">Hsieh <italic>et al</italic>. (2003)</xref>], have been investigated in Japanese women but do not appear to influence endometriosis susceptibility in this population (<xref ref-type="bibr" rid="DMN040C80">Kitawaki <italic>et al</italic>., 2002</xref>). However, the same research group found that the genotype for the CA repeat microsatellite in the interferon-&#x003b3; gene may have an effect on endometriosis susceptibility in Japanese women (<xref ref-type="bibr" rid="DMN040C81">Kitawaki <italic>et al</italic>., 2004</xref>). Polymorphisms in genes encoding other interleukins (IL-1&#x003b2;, IL-4, IL-6 and IL-18) and their receptors (IL-1 receptor and IL-12 receptor &#x003b2;) have been investigated but failed to show a consistent association with endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C45">Hsieh <italic>et al</italic>., 2001a</xref>, <xref ref-type="bibr" rid="DMN040C48">2002</xref>, <xref ref-type="bibr" rid="DMN040C55">2005b</xref>; <xref ref-type="bibr" rid="DMN040C88">Lee <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C135">Wieser <italic>et al</italic>., 2003a</xref>, <xref ref-type="bibr" rid="DMN040C136">b</xref>; <xref ref-type="bibr" rid="DMN040C15">Bhanoori <italic>et al</italic>., 2005b</xref>; <xref ref-type="bibr" rid="DMN040C82">Kitawaki <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="DMN040C129">Wen <italic>et al</italic>., 2006</xref>). <xref ref-type="bibr" rid="DMN040C135">Wieser <italic>et al</italic>. (2003a)</xref> suggest that the IL-6 promoter polymorphism 174G/C predisposes women to endometriosis with chocolate cysts. In one study, carriage of the IL-1 receptor antagonist A2 allele was associated with endometriosis in a Chinese population (<xref ref-type="bibr" rid="DMN040C129">Wen <italic>et al</italic>., 2006</xref>). <xref ref-type="bibr" rid="DMN040C22">D&#x02019;Amora <italic>et al</italic>. (2006)</xref> also reported that the BsrBI C/A, but not the PstI C/T polymorphism of the IL-1 receptor gene, is associated with a reduced risk of endometriosis.</p><p>The insulin-like growth factor II (IGF2) ApaI polymorphism was not found to be associated with endometriosis in Taiwanese women (<xref ref-type="bibr" rid="DMN040C52">Hsieh <italic>et al</italic>., 2004c</xref>). Also, a polymorphism in the <italic>TGF</italic> beta 1 gene (509C/T) was not associated with deep infiltrating endometriosis in Dutch women (<xref ref-type="bibr" rid="DMN040C119">van Kaam <italic>et al</italic>., 2007a</xref>).</p><p>A number of groups have investigated a possible link between polymorphisms in the tumour necrosis factor (<italic>TNF</italic>) gene and increased endometriosis risk. Polymorphisms in the promoter region of the TNF-&#x003b1; gene do not appear to influence endometriosis risk in Korean, Taiwanese or Caucasian women (<xref ref-type="bibr" rid="DMN040C48">Hsieh <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C88">Lee <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C132">Wieser <italic>et al</italic>., 2002a</xref>). An Australian study investigating 26 polymorphisms in the promoter and coding regions of TNF also found no association with endometriosis (<xref ref-type="bibr" rid="DMN040C141">Zhao <italic>et al</italic>., 2007</xref>). However, the &#x02212;1031T/C <italic>TNF</italic> promoter polymorphism may affect disease severity in Japanese women (<xref ref-type="bibr" rid="DMN040C6">Asghar <italic>et al</italic>., 2004</xref>). In Japanese women, the TNF-U01 haplotype (&#x02212;1031T, &#x02212;863C, &#x02212;857C) has also been linked to endometriosis susceptibility, although it should be noted that this haplotype is in strong linkage disequilibrium with the <italic>HLA-B</italic>*<italic>0702</italic> allele, making it difficult to determine which gene is responsible for the association (<xref ref-type="bibr" rid="DMN040C111">Teramoto <italic>et al</italic>., 2004</xref>). A Chinese study found an association between endometriosis and the +252 polymorphism in intron 1 of the <italic>TNF</italic> beta gene (<xref ref-type="bibr" rid="DMN040C93">Luo <italic>et al</italic>., 2006</xref>).</p></sec><sec id="s4a2"><title>Nitric oxide and adhesion molecules</title><p>Elevated levels of the pro-inflammatory molecule nitric oxide (NO) have been reported in women with endometriosis (<xref ref-type="bibr" rid="DMN040C137">Wu <italic>et al</italic>., 2003</xref>). Endothelial NO synthase catalyses the production of NO, and the p.E298D polymorphism in the <italic>NOS3</italic> gene has been associated with endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C139">Zervou <italic>et al</italic>., 2003</xref>). Intercellular adhesion molecule-1 (ICAM-1) is thought to mediate interactions between endometrial cells and lymphocytes during the pathogenesis of endometriosis (<xref ref-type="bibr" rid="DMN040C122">Vigano <italic>et al</italic>., 2003</xref>). In Caucasian women, the p.G241R polymorphism in the <italic>ICAM1</italic> gene may influence disease severity (<xref ref-type="bibr" rid="DMN040C122">Vigano <italic>et al</italic>., 2003</xref>), but neither this nor the p.K469E polymorphism appear to have a direct influence on endometriosis susceptibility in either Caucasian or Japanese women (<xref ref-type="bibr" rid="DMN040C122">Vigano <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C138">Yamashita <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C82">Kitawaki <italic>et al</italic>., 2006</xref>). The PmII C/T polymorphism of the epithelial cadherin (<italic>CDH1</italic>) gene was associated with late-stage endometriosis in Taiwanese women (<xref ref-type="bibr" rid="DMN040C56">Hsieh <italic>et al</italic>., 2005c</xref>). In a Chinese study, the <italic>CDH1</italic> 3&#x02032;-UTR C/T polymorphism, but not the &#x02212;160C/A or &#x02212;347G/GA promoter polymorphisms, was associated with endometriosis (<xref ref-type="bibr" rid="DMN040C106">Shan <italic>et al</italic>., 2007</xref>).</p></sec><sec id="s4a3"><title>Human leukocyte antigens</title><p>Human leukocyte antigens (HLAs) are key components of the major histocompatibility complex (MHC), which is involved in immune cell signalling processes such as T-cell activation. HLA genes involved in both MHC I (<italic>HLA-A</italic> and <italic>HLA-B</italic>) and MHC II (<italic>HLA-DPB1</italic>, <italic>HLA-DQB1</italic> and <italic>HLA-DRB1</italic>) have been studied in women with endometriosis. A study of Chinese women found that <italic>HLA-B</italic> genotype, but not <italic>HLA-A</italic> genotype, influences endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C125">Wang <italic>et al</italic>., 2001</xref>). In Japanese women, both the <italic>HLA-DRB1*1403</italic> and <italic>HLA-DQB1*0301</italic> alleles have been linked to increased endometriosis risk, whereas <italic>HLA-DPB1</italic> alleles do not appear to affect susceptibility (<xref ref-type="bibr" rid="DMN040C66">Ishii <italic>et al</italic>., 2002</xref>, <xref ref-type="bibr" rid="DMN040C67">2003</xref>). It should be noted that the <italic>HLA-DRB1</italic> and <italic>HLA-DQB1</italic> genes are in strong linkage disequilibrium (<xref ref-type="bibr" rid="DMN040C23">de Bakker <italic>et al</italic>., 2006</xref>), which may explain why they both show an association with endometriosis. Studies of Chinese and Korean women investigating many of the known alleles of the <italic>HLA-DRB1</italic> gene found no association between these alleles and endometriosis susceptibility in these populations (<xref ref-type="bibr" rid="DMN040C126">Wang <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C131">Whang <italic>et al</italic>., 2006</xref>). Two polymorphisms in the cytotoxic T lymphocyte antigen 4 (<italic>CTLA</italic>-4) gene were found not to be associated with endometriosis (<xref ref-type="bibr" rid="DMN040C123">Vigano <italic>et al</italic>., 2005</xref>).</p></sec><sec id="s4a4"><title>Regulation upon activation normal T-cell expressed and secreted</title><p>Regulation upon Activation Normal T cell Expressed and Secreted (RANTES, recently renamed <italic>CCL5</italic>) is an inflammatory cytokine that has been implicated in the induction of monocyte migration in the peritoneal fluid of women with endometriosis (<xref ref-type="bibr" rid="DMN040C102">Pritts <italic>et al</italic>., 2002</xref>). Although the &#x02212;403G/A and &#x02212;28C/G polymorphisms in the <italic>CCL5</italic> gene and the delta32 and p.V64I polymorphisms in the RANTES receptor genes, <italic>CCR5</italic> and <italic>CCR2</italic>, respectively, do not appear to affect endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C2">Antinolo <italic>et al</italic>., 2003</xref>, <xref ref-type="bibr" rid="DMN040C3">2004</xref>), the p.P12A polymorphism in the gene encoding PPAR-&#x003b3; (<italic>PPARG</italic>), which regulates the expression of <italic>CCL5</italic>, has been linked to an increased risk of endometriosis (<xref ref-type="bibr" rid="DMN040C27">Dogan <italic>et al</italic>., 2004</xref>). On the other hand, no association was found in Japanese women between the <italic>PPARG</italic> p.P12A polymorphism and endometriosis, but an association was found with the exon 6 161C/T polymorphism in that same gene (<xref ref-type="bibr" rid="DMN040C83">Kiyomizu <italic>et al</italic>., 2006</xref>).</p></sec><sec id="s4a5"><title>Summary</title><p>No consistent evidence linking endometriosis with specific polymorphisms of genes coding for inflammatory mediators is available. A number of polymorphisms have been found to be associated with endometriosis in selected populations (Table&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>). However, these associations have not been independently confirmed across ethnic barriers, either because only single studies are available or because other studies investigating these polymorphisms reported no association. Nor have meta-analyses of these studies been published. Therefore, no specific polymorphisms of genes encoding inflammatory mediators have been convincingly shown to play a role in the susceptibility to endometriosis.</p></sec></sec><sec id="s4b"><title>Genes involved in sex hormone activity</title><p>Investigations of the influence of polymorphisms in genes encoding sex hormones and hormone regulators are set out in Table&#x000a0;<xref ref-type="table" rid="DMN040TB2">II</xref>.</p><table-wrap id="DMN040TB2" position="float"><label>Table II</label><caption><p>Polymorphisms of genes encoding sex hormones and hormone regulators, which have been investigated for their role in endometriosis</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene (locus, protein name and its function)</th><th align="left" colspan="2" rowspan="1">Variant<hr/></th><th align="left" colspan="2" rowspan="1">Association with susceptibility<hr/></th><th align="left" rowspan="1" colspan="1">Phenotype</th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Name</th><th align="left" rowspan="1" colspan="1">dbSNP ID</th><th align="left" rowspan="1" colspan="1">Positive (number of cases, number of controls)</th><th align="left" rowspan="1" colspan="1">Negative (number of cases, number of controls)</th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>AR</italic> (Xq11.2-q12, androgen receptor gene: hormone receptor)</td><td rowspan="1" colspan="1">CAG repeat (exon 1)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (110, 99) (<xref ref-type="bibr" rid="DMN040C46">Hsieh <italic>et al</italic>., 2001b</xref>)</td><td rowspan="1" colspan="1">Italian women (105, 92) (<xref ref-type="bibr" rid="DMN040C86">Lattuada <italic>et al</italic>., 2004c</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>ESR1</italic> (6q25.1, estrogen receptor &#x003b1;: hormone receptor)</td><td rowspan="1" colspan="1">TA repeat (promoter)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Greek women (57, 57) (<xref ref-type="bibr" rid="DMN040C35">Georgiou <italic>et al</italic>., 1999</xref>)<break/>Taiwanese women (119, 108) (<xref ref-type="bibr" rid="DMN040C57">Hsieh <italic>et al</italic>., 2005d</xref>)<break/>Korean women (180, 165) (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women; disease stage and disease susceptibility (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">PvuII RFLP<break/>(&#x02212;397T/C) (IVS1<break/>&#x02212;401T/C)</td><td rowspan="1" colspan="1">rs2234693</td><td rowspan="1" colspan="1">Greek women (57, 57) (<xref ref-type="bibr" rid="DMN040C35">Georgiou <italic>et al</italic>., 1999</xref>)<break/>Italian women (61<sup>&#x02020;</sup>) (<xref ref-type="bibr" rid="DMN040C92">Luisi <italic>et al</italic>., 2006</xref>)<break/>Japanese women (203, 179) (<xref ref-type="bibr" rid="DMN040C79">Kitawaki <italic>et al</italic>., 2001</xref>)<break/>Taiwanese women (112, 110) (<xref ref-type="bibr" rid="DMN040C62">Hsieh <italic>et al</italic>., 2007b</xref>)</td><td rowspan="1" colspan="1">Korean women (180, 165) (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>)<break/>Japanese women (132, 182) (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>)<break/>Austrian women (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1">German women (98, 98); disease severity, haplotype with rs7340799 (<xref ref-type="bibr" rid="DMN040C103">Renner <italic>et al</italic>., 2006</xref>)<break/>Egyptian women (23<sup>&#x02020;</sup>); disease severity (<xref ref-type="bibr" rid="DMN040C28">El-Gindi <italic>et al</italic>., 2002</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">XbaI RFLP (&#x02212;351A/G)</td><td rowspan="1" colspan="1">rs7340799</td><td rowspan="1" colspan="1">Taiwanese women (112 EM, 106 LM, 110C) (<xref ref-type="bibr" rid="DMN040C62">Hsieh <italic>et al</italic>., 2007b</xref>)</td><td rowspan="1" colspan="1">Italian women (61<sup>&#x02020;</sup>) (<xref ref-type="bibr" rid="DMN040C92">Luisi <italic>et al</italic>., 2006</xref>)<break/>Japanese women (132, 182) (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>)<break/>Korean women (180, 165) (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1">German women (98, 98)); disease severity, haplotype with rs2234693 (<xref ref-type="bibr" rid="DMN040C103">Renner <italic>et al</italic>., 2006</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>ESR2</italic> (14q23.2, estrogen receptor &#x003b2;: hormone receptor)</td><td rowspan="1" colspan="1">RsaI RFLP (1082G/A)</td><td rowspan="1" colspan="1">rs1256049</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (132, 182) (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">AluI RFLP (1730A/G)</td><td rowspan="1" colspan="1">rs4986938</td><td rowspan="1" colspan="1">Japanese women (132, 182) (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1">Italian women (61<sup>&#x02020;</sup>) (<xref ref-type="bibr" rid="DMN040C92">Luisi <italic>et al</italic>., 2006</xref>)<break/>Korean women (239, 287) (<xref ref-type="bibr" rid="DMN040C89">Lee <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1">Japanese women; disease severity (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>NRIP1</italic> (21q11.2, receptor interacting protein 140: estrogen and progesterone receptor cofactor)</td><td rowspan="1" colspan="1">p.R448G</td><td rowspan="1" colspan="1">rs2229742</td><td rowspan="1" colspan="1">Spanish women (59, 141) (<xref ref-type="bibr" rid="DMN040C18">Caballero <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>PGR</italic> (11q22-q23, progesterone receptor: hormone receptor)</td><td rowspan="1" colspan="1">331A/G</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs10895068</td><td rowspan="1" colspan="1">Dutch women (72, 93) (<xref ref-type="bibr" rid="DMN040C120">van Kaam <italic>et al</italic>., 2007b</xref>)</td><td rowspan="1" colspan="1">Dutch women; risk of deep infiltrating endometriosis (<xref ref-type="bibr" rid="DMN040C120">van Kaam <italic>et al</italic>., 2007b</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td colspan="2" rowspan="1">PROGINS (320 bp PV/HS-1 Alu insertion in intron G and 2 SNPs: rs1042838 in exon 4 and rs104839 in exon 5)</td><td rowspan="1" colspan="1">Austrian women (95, 107) (<xref ref-type="bibr" rid="DMN040C133">Wieser <italic>et al</italic>., 2002b</xref>)<break/>Brazilian women (121, 281) (<xref ref-type="bibr" rid="DMN040C24">De Carvalho <italic>et al</italic>., 2007</xref>) signif. assoc.<break/>Italian women (131, 127) (<xref ref-type="bibr" rid="DMN040C84">Lattuada <italic>et al</italic>., 2004a</xref>)</td><td rowspan="1" colspan="1">Australian European women (980 triads<sup>&#x02021;</sup>) (<xref ref-type="bibr" rid="DMN040C114">Treloar <italic>et al</italic>., 2005a</xref>, <xref ref-type="bibr" rid="DMN040C115">b</xref>)<break/>Dutch women (72, 93) (<xref ref-type="bibr" rid="DMN040C120">van Kaam <italic>et al</italic>., 2007b</xref>)<break/>Indian women (100, 108) (<xref ref-type="bibr" rid="DMN040C37">Govindan <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Genes are grouped alphabetically, and studies showing positive or negative associations of these genes with disease susceptibility and/or positive associations with phenotype are presented. <sup>&#x02020;</sup>Not a case&#x02013;control study; <sup>&#x02021;</sup>Parent&#x02013;offspring study. RFLP, restriction fragment-length polymorphism; SNP, single-nucleotide polymorphism.</p></fn></table-wrap-foot></table-wrap><sec id="s4b1"><title>Estrogen receptor</title><p>The influence of estrogen receptor gene (<italic>ESR1</italic>) polymorphisms has been investigated both in European and in Asian women with endometriosis. The XbaI (&#x02212;351A/G) and the PvuII (&#x02212;397T/C) restriction fragment-length polymorphisms (RFLPs) were not associated with endometriosis in a Korean population (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>), but appear to affect endometriosis susceptibility in Taiwanese women (<xref ref-type="bibr" rid="DMN040C62">Hsieh <italic>et al</italic>., 2007b</xref>). The association between endometriosis and the PvuII RFLP (&#x02212;397T/C) was also found in Greek and Italian women (<xref ref-type="bibr" rid="DMN040C35">Georgiou <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="DMN040C92">Luisi <italic>et al</italic>., 2006</xref>), and has been shown to influence disease severity, but not susceptibility, in German and Egyptian women (<xref ref-type="bibr" rid="DMN040C28">El-Gindi <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C103">Renner <italic>et al</italic>., 2006</xref>). This polymorphism was not found to affect endometriosis susceptibility in Korean women (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>), and studies investigating its importance in Japanese women have reported conflicting results (<xref ref-type="bibr" rid="DMN040C79">Kitawaki <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>). An Austrian group investigated the effect of the <italic>ESR1</italic> &#x02212;397T/C polymorphism, which they named IVS1&#x02212;401T/C, but found no association with endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>). A TA repeat microsatellite upstream of the <italic>ESR1</italic> gene has been linked to endometriosis susceptibility in Greek, Taiwanese and Korean women (<xref ref-type="bibr" rid="DMN040C35">Georgiou <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>; <xref ref-type="bibr" rid="DMN040C57">Hsieh <italic>et al</italic>., 2005d</xref>), and has been associated with susceptibility to mild endometriosis in Korean women (<xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>). Studies of Japanese, Korean and Italian women found no link between the XbaI RFLP (&#x02212;351A/C) in the <italic>ESR1</italic> gene and endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="DMN040C76">Kim <italic>et al</italic>., 2005b</xref>; <xref ref-type="bibr" rid="DMN040C92">Luisi <italic>et al</italic>., 2006</xref>), although a study of German women suggested that it may influence lesion severity (<xref ref-type="bibr" rid="DMN040C103">Renner <italic>et al</italic>., 2006</xref>). The AluI RFLP (1730A/G) in the <italic>ESR2</italic> gene was linked to an increased risk of stage IV endometriosis in Japanese women (<xref ref-type="bibr" rid="DMN040C127">Wang <italic>et al</italic>., 2004</xref>), but was not shown to influence disease susceptibility in groups of Italian and Korean women (<xref ref-type="bibr" rid="DMN040C92">Luisi <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="DMN040C89">Lee <italic>et al</italic>., 2007</xref>).</p></sec><sec id="s4b2"><title>Progesterone receptor</title><p>Groups in Austria, Brazil and Italy have demonstrated a link between the PROGINS polymorphism in the <italic>PGR</italic> gene and endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C133">Wieser <italic>et al</italic>., 2002b</xref>; <xref ref-type="bibr" rid="DMN040C84">Lattuada <italic>et al</italic>., 2004a</xref>; <xref ref-type="bibr" rid="DMN040C24">De Carvalho <italic>et al</italic>., 2007</xref>). A study of Dutch women with deep infiltrating endometriosis found no association with PROGINS, but did observe an association with the <italic>PGR</italic> 331G/A polymorphism (<xref ref-type="bibr" rid="DMN040C120">van Kaam <italic>et al</italic>., 2007b</xref>). A study from India (<xref ref-type="bibr" rid="DMN040C37">Govindan <italic>et al</italic>., 2007</xref>) and an analysis of pooled data from an Australian group who conducted several studies investigating the PROGINS polymorphism and five SNPs in the <italic>PGR</italic> gene, indicated that there was no association with endometriosis susceptibility for any of these variants (<xref ref-type="bibr" rid="DMN040C114">Treloar <italic>et al</italic>., 2005a</xref>).</p></sec><sec id="s4b3"><title>Androgen receptor</title><p>The CAG repeat microsatellite in the <italic>AR</italic> gene has been linked to an increased risk of uterine fibroids, and the 21 CAG repeat allele showed an association with endometriosis susceptibility in Taiwanese women (<xref ref-type="bibr" rid="DMN040C46">Hsieh <italic>et al</italic>., 2001b</xref>). However, an Italian study found no association between CAG repeat length and endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C86">Lattuada <italic>et al</italic>., 2004c</xref>). Receptor interacting protein 140 co-regulates the activities of estrogen and progesterone receptors and is essential for female fertility (<xref ref-type="bibr" rid="DMN040C18">Caballero <italic>et al</italic>., 2005</xref>). The p.R448G polymorphism in the gene encoding this protein (<italic>NRIP1</italic>) has been linked to endometriosis susceptibility in Spanish women (<xref ref-type="bibr" rid="DMN040C18">Caballero <italic>et al</italic>., 2005</xref>).</p></sec><sec id="s4b4"><title>Summary</title><p>No consistent evidence linking specific polymorphisms of genes encoding proteins involved in sex hormone activity with endometriosis is available. A number of polymorphisms have been found to be associated with endometriosis in selected populations (Table&#x000a0;<xref ref-type="table" rid="DMN040TB2">II</xref>). However, these associations have not been independently confirmed across ethnic barriers, either because only single studies are available or because other studies investigating the respective polymorphisms reported no association. A systematic review and meta-analysis of studies investigating sex steroid biosynthesis and sex steroid receptors in women with endometriosis has been published, demonstrating no consistent association of the investigated polymorphisms with endometriosis (<xref ref-type="bibr" rid="DMN040C39">Guo, 2006a</xref>). Therefore, no specific polymorphisms of genes encoding proteins involved in sex hormone activity have been convincingly shown to play a role in the susceptibility to endometriosis.</p></sec></sec><sec id="s4c"><title>Metabolic enzymes</title><sec id="s4c1"><title>17-&#x003b2; hydroxysteroid dehydrogenase type 1</title><p>The 17-&#x003b2; hydroxysteroid dehydrogenase type 1 (<italic>HSD17B1)</italic> gene encodes a key enzyme involved in testosterone biosynthesis and estrogen metabolism. The p.S312G polymorphism in this gene has been linked to an increased risk of endometriosis in Japanese women (<xref ref-type="bibr" rid="DMN040C118">Tsuchiya <italic>et al</italic>., 2005b</xref>), and the &#x02212;27A/C (vIV) polymorphism was associated with an increased risk of endometriosis in a cohort of Austrian women (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>).</p></sec><sec id="s4c2"><title>Detoxification enzymes</title><p>The <italic>CYP1A1</italic> and <italic>CYP1B1</italic> genes encode phase I detoxification enzymes involved in estrogen metabolism. Studies in Austrian, Indian, Chinese, Japanese and Taiwanese populations found no association between known polymorphisms in the <italic>CYP1A1</italic> gene and susceptibility to endometriosis (<xref ref-type="bibr" rid="DMN040C99">Peng <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C65">Iizuka <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C9">Babu <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C70">Juo <italic>et al</italic>., 2006</xref>). However, studies in Greece and the UK indicated that the MspI RFLP (6235T/C) in the <italic>CYP1A1</italic> gene may influence endometriosis susceptibility when associated with the <italic>GSTM1</italic> null deletion variant (<xref ref-type="bibr" rid="DMN040C4">Arvanitis <italic>et al</italic>., 2001</xref>, <xref ref-type="bibr" rid="DMN040C5">2003</xref>; <xref ref-type="bibr" rid="DMN040C42">Hadfield <italic>et al</italic>., 2001</xref>). <xref ref-type="bibr" rid="DMN040C100">Peng <italic>et al</italic>. (2003a)</xref> reported that the CYP1A1 4889A/G polymorphism is associated with endometriosis in Chinese women. An Austrian group investigated the p.N453S polymorphism in the <italic>CYP1B1</italic> gene but this did not appear to influence susceptibility to endometriosis (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>). In a Korean study, the CYP1B1 p.L432V, Asp(449)C/T and p.A453S polymorphisms were not associated with late stage endometriosis (<xref ref-type="bibr" rid="DMN040C20">Cho <italic>et al</italic>., 2007</xref>). Polymorphisms in genes encoding other enzymes involved in estrogen metabolism (<italic>COMT</italic>) or phase I detoxification (myeloperoxidase) have also been investigated, but failed to show an effect on endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C134">Wieser <italic>et al</italic>., 2002c</xref>; <xref ref-type="bibr" rid="DMN040C50">Hsieh <italic>et al</italic>., 2004a</xref>; <xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C70">Juo <italic>et al</italic>., 2006</xref>).</p><p>The <italic>CYP17A1</italic> and <italic>CYP19A1</italic> genes both code for enzymes involved in estrogen biosynthesis. Whereas studies of Taiwanese women have shown a possible relation between endometriosis susceptibility and the &#x02212;34T/C polymorphism in the promoter region of the <italic>CYP17A1</italic> gene (<xref ref-type="bibr" rid="DMN040C51">Hsieh <italic>et al</italic>., 2004b</xref>, <xref ref-type="bibr" rid="DMN040C57">2005d</xref>), no strong association with <italic>CYP17A1</italic> polymorphisms has been found in UK, Brazilian, Austrian, Taiwanese or Japanese study populations (<xref ref-type="bibr" rid="DMN040C71">Kado <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C7">Asghar <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C70">Juo <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="DMN040C24">De Carvalho <italic>et al</italic>., 2007</xref>). The TTTA repeat microsatellite in the <italic>CYP19A1</italic> gene may increase the risk of endometriosis in Greek women (<xref ref-type="bibr" rid="DMN040C5">Arvanitis <italic>et al</italic>., 2003</xref>), and shows a weak association in Japanese women (<xref ref-type="bibr" rid="DMN040C71">Kado <italic>et al</italic>., 2002</xref>). Another polymorphism in this gene (p.R264C) was studied in Japanese and Austrian women, but did not appear to influence endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C118">Tsuchiya <italic>et al</italic>., 2005b</xref>).</p><p>The <italic>GSTM1, GSTP1, GSTT1</italic>, <italic>NAT1</italic> and <italic>NAT2</italic> genes all encode phase II detoxification enzymes. Null deletions in the glutathione-<italic>S</italic>-transferase <italic>GSTM1</italic> gene have been linked to an increased risk of endometriosis in French, Russian, Indian, Chinese and Taiwanese women (<xref ref-type="bibr" rid="DMN040C10">Baranova <italic>et al</italic>., 1997</xref>, <xref ref-type="bibr" rid="DMN040C11">1999</xref>; <xref ref-type="bibr" rid="DMN040C69">Ivashchenko <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C101">Peng <italic>et al</italic>., 2003b</xref>; <xref ref-type="bibr" rid="DMN040C50">Hsieh <italic>et al</italic>., 2004a</xref>; <xref ref-type="bibr" rid="DMN040C9">Babu <italic>et al</italic>., 2005</xref>). These null deletions were not shown to affect endometriosis susceptibility in Korean, Japanese and Australian study populations (<xref ref-type="bibr" rid="DMN040C12">Baxter <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="DMN040C65">Iizuka <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C95">Morizane <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="DMN040C64">Hur <italic>et al</italic>., 2005</xref>), although the Australian study indicated that <italic>GSTM1</italic> null deletion may predispose endometrial lesions to malignant transformation (<xref ref-type="bibr" rid="DMN040C12">Baxter <italic>et al</italic>., 2001</xref>). The p.I105V polymorphism in the <italic>GSTP1</italic> gene is associated with an increased risk of endometriosis in Turkish women (<xref ref-type="bibr" rid="DMN040C29">Ertunc <italic>et al</italic>., 2005</xref>), but does not seem to have an effect on susceptibility in Korean women (<xref ref-type="bibr" rid="DMN040C64">Hur <italic>et al</italic>., 2005</xref>). Studies conducted in Greece, France, India, UK, Japan and Korea showed no correlation between the <italic>GSTT1</italic> null deletion variant and endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C11">Baranova <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="DMN040C5">Arvanitis <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C95">Morizane <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="DMN040C9">Babu <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C64">Hur <italic>et al</italic>., 2005</xref>), whereas a study of Russian women did show such an association (<xref ref-type="bibr" rid="DMN040C69">Ivashchenko <italic>et al</italic>., 2003</xref>). Several studies have investigated the association between <italic>NAT2</italic> polymorphisms and endometriosis susceptibility, but they reported conflicting results (<xref ref-type="bibr" rid="DMN040C11">Baranova <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="DMN040C97">Nakago <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="DMN040C65">Iizuka <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C69">Ivashchenko <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="DMN040C8">Babu <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="DMN040C25">Deguchi <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C68">Iskhakova, 2006</xref>). One study investigated <italic>NAT1</italic> polymorphisms and found no association with endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C25">Deguchi <italic>et al</italic>., 2005</xref>).</p><p>The arylhydrocarbon receptor (AhR) and the AhR nuclear translocator (ARNT) are transcription factors that promote the expression of a number of genes encoding metabolic enzymes (including <italic>CYP1A1</italic> and <italic>GST</italic>). The action of AhR is suppressed by the AhR repressor (AhRR). In Japanese women, the p.A185P polymorphism in the <italic>AHRR</italic> gene has been shown to confer endometriosis susceptibility and severity, but polymorphisms in the <italic>AHR</italic> and <italic>ARNT</italic> genes did not have an effect (<xref ref-type="bibr" rid="DMN040C117">Tsuchiya <italic>et al</italic>., 2005a</xref>). In a Korean study, concomitant carriage of the p.A185P polymorphism in the <italic>AHRR</italic> gene and the <italic>GSTT1</italic> null deletion, but not carriage of <italic>AHRR</italic> p.A185P, <italic>GSTT1</italic> null deletion or <italic>GSTM1</italic> null deletion alone, was associated with endometriosis (<xref ref-type="bibr" rid="DMN040C78">Kim <italic>et al</italic>., 2007b</xref>). The <italic>AHRR</italic> p.A185P polymorphism was not associated with endometriosis in Japanese women (<xref ref-type="bibr" rid="DMN040C128">Watanabe <italic>et al</italic>., 2001</xref>).</p></sec><sec id="s4c3"><title>Summary</title><p>The most solid evidence so far linking specific polymorphisms to endometriosis comes from studies investigating phase II detoxification enzymes, namely the <italic>GSTT1</italic> null deletion variant. A systematic review and meta-analysis of the <italic>GSTM1</italic> and <italic>GSTT1</italic> variants demonstrated a consistent association between <italic>GSTT1</italic> polymorphisms and endometriosis with a moderate effect size. There was a 29% increased risk of endometriosis in <italic>GSTT1</italic> null deletion carriers (<xref ref-type="bibr" rid="DMN040C38">Guo, 2005</xref>). It has to be mentioned, however, that there was evidence of publication bias in this meta-analysis, indicating that the size of the increased risk associated with the <italic>GSTT1</italic> deletion variant may actually be smaller or non-existent. In addition, a number of polymorphisms have been found to be associated with endometriosis in selected populations, e.g. <italic>HSD17B1</italic> p.S312G and &#x02212;27A/C (vIV), <italic>CYP1A1</italic> MspI RFLP (6235T/C), <italic>NAT2</italic>*5, <italic>CYP17A1</italic> &#x02212;34T/C, <italic>CYP19A1</italic> TTTA repeat microsatellite and <italic>AHRR</italic> p.A185P (Table&#x000a0;<xref ref-type="table" rid="DMN040TB3">III</xref>). These associations, however, have not been independently confirmed across ethnic barriers either because only single studies are available or because other studies investigating these polymorphisms reported no association.</p><table-wrap id="DMN040TB3" position="float"><label>Table III</label><caption><p>Polymorphisms of genes encoding enzymes involved in metabolism and biosynthesis, which have been investigated for their role in endometriosis</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene (locus, protein name and its function)</th><th align="left" colspan="2" rowspan="1">Variant<hr/></th><th align="left" colspan="2" rowspan="1">Association with susceptibility<hr/></th><th align="left" rowspan="1" colspan="1">Phenotype</th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Name</th><th align="left" rowspan="1" colspan="1">dbSNP ID</th><th align="left" rowspan="1" colspan="1">Positive</th><th align="left" rowspan="1" colspan="1">Negative</th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>AHR</italic> (7p15, arylhydrocarbon receptor: transcription factor, detoxification)</td><td rowspan="1" colspan="1">p.K554R</td><td rowspan="1" colspan="1">rs2066853</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (79, 59) (<xref ref-type="bibr" rid="DMN040C117">Tsuchiya <italic>et al</italic>., 2005a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>ARNT</italic> (7p15, arylhydrocarbon receptor nuclear translocator: transcription factor, detoxification)</td><td rowspan="1" colspan="1">567G/C (p.V189V)</td><td rowspan="1" colspan="1">rs2228099</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (79, 59) (<xref ref-type="bibr" rid="DMN040C117">Tsuchiya <italic>et al</italic>., 2005a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>AHRR</italic> (5p15.3, arylhydrocarbon receptor repressor: transcription factor repressor, detoxification)</td><td rowspan="1" colspan="1">p.A185P</td><td rowspan="1" colspan="1">rs2292596</td><td rowspan="1" colspan="1">Japanese women (79, 59) (<xref ref-type="bibr" rid="DMN040C117">Tsuchiya <italic>et al</italic>., 2005a</xref>)<break/>Korean women, in association with GSTT1 null deletion (316, 256) (<xref ref-type="bibr" rid="DMN040C78">Kim <italic>et al</italic>., 2007b</xref>)</td><td rowspan="1" colspan="1">Japanese women (45, 108) (<xref ref-type="bibr" rid="DMN040C128">Watanabe <italic>et al</italic>., 2001</xref>)<break/>No differences found</td><td rowspan="1" colspan="1">Japanese women; disease severity (79, 59) (<xref ref-type="bibr" rid="DMN040C117">Tsuchiya <italic>et al</italic>., 2005a</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>COMT</italic> (22q11.21, catechol-<italic>O</italic>-methyl transferase: steroid biosynthesis, Estrogen metabolism)</td><td rowspan="1" colspan="1">p.V158M</td><td rowspan="1" colspan="1">rs4680</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Austrian women (91, 92) (<xref ref-type="bibr" rid="DMN040C134">Wieser <italic>et al</italic>., 2002c</xref>); (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)<break/>Taiwanese women (105, 312) ((<xref ref-type="bibr" rid="DMN040C70">Juo <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CYP1A1</italic> (15q22-q24, cytochrome P450 1A1 enzyme: steroid biosynthesis, Estrogen metabolism, phase I detoxification)</td><td rowspan="1" colspan="1">MspI RFLP (6235T/C) (3801T/C) (m1)</td><td rowspan="1" colspan="1">rs4646903</td><td rowspan="1" colspan="1">Greek women; alone or in combination with GSTM1 null deletion (5<sup>&#x02020;</sup>, 54) (<xref ref-type="bibr" rid="DMN040C4">Arvanitis <italic>et al</italic>., 2001</xref>); in combination with GSTM1 null deletion (275, 346) (<xref ref-type="bibr" rid="DMN040C5">Arvanitis <italic>et al</italic>., 2003</xref>; Cretan Greek women)<break/>UK, mainly Caucasian women; in combination with GSTM1 null deletion (101; 154 + 192 in sib pair analysis) (<xref ref-type="bibr" rid="DMN040C42">Hadfield <italic>et al</italic>., 2001</xref>)</td><td rowspan="1" colspan="1">Chinese women (76, 80) (<xref ref-type="bibr" rid="DMN040C99">Peng <italic>et al</italic>., 2002</xref>)<break/>Taiwanese women of Chinese descent (105, 312) (<xref ref-type="bibr" rid="DMN040C70">Juo <italic>et al</italic>., 2006</xref>)<break/>Austrian women (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)<break/>South Indian women (310, 215) (<xref ref-type="bibr" rid="DMN040C9">Babu <italic>et al</italic>., 2005</xref>)<break/>Japanese women (35, 37) (<xref ref-type="bibr" rid="DMN040C65">Iizuka <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.I462V<break/>4889A/G (m2)</td><td rowspan="1" colspan="1">rs1048943</td><td rowspan="1" colspan="1">Chinese women (76, 80) (<xref ref-type="bibr" rid="DMN040C100">Peng <italic>et al</italic>., 2003a</xref>)</td><td rowspan="1" colspan="1">Chinese women (76, 80) (<xref ref-type="bibr" rid="DMN040C99">Peng <italic>et al</italic>., 2002</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CYP1B1</italic> (2p21, cytochrome P450 1B1 enzyme: steroid biosynthesis, Estrogen metabolism, phase I detoxification)</td><td rowspan="1" colspan="1">p.N453S</td><td rowspan="1" colspan="1">rs1800440</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Austrian women (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.L432V, p.D449D(C/T), p.N453S, p.A119S</td><td rowspan="1" colspan="1">rs1056836, rs1056837, rs1800440, rs1056827</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women (221, 188) (<xref ref-type="bibr" rid="DMN040C20">Cho <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CYP17A1</italic> (10q24.3, cytochrome P450 17 enzyme: estrogen biosynthesis)</td><td rowspan="1" colspan="1">MspA1 RFLP (&#x02212;34T/C)</td><td rowspan="1" colspan="1">rs743572</td><td rowspan="1" colspan="1">Taiwanese women (119, 128) (<xref ref-type="bibr" rid="DMN040C51">Hsieh <italic>et al</italic>., 2004b</xref>); (119, 108) (<xref ref-type="bibr" rid="DMN040C57">Hsieh <italic>et al</italic>., 2005d</xref>)</td><td rowspan="1" colspan="1">Brazilian women (121, 281) (<xref ref-type="bibr" rid="DMN040C24">De Carvalho <italic>et al</italic>., 2007</xref>)<break/>Japanese women (140, 177) (<xref ref-type="bibr" rid="DMN040C71">Kado <italic>et al</italic>., 2002</xref>)<break/>UK (94, 97) and Japanese women (130, 179)<break/>(<xref ref-type="bibr" rid="DMN040C7">Asghar <italic>et al</italic>., 2005</xref>)<break/>Austrian women (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)<break/>Taiwanese women (198, 312) (<xref ref-type="bibr" rid="DMN040C70">Juo <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CYP19A1</italic> (<italic>15q21.1</italic>, aromatase: steroid biosynthesis)</td><td rowspan="1" colspan="1">TTTA repeat microsatellite</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Greek women (275, 346) (<xref ref-type="bibr" rid="DMN040C5">Arvanitis <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1">Japanese women; chocolate cysts (140, 177) (<xref ref-type="bibr" rid="DMN040C71">Kado <italic>et al</italic>., 2002</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.R264C</td><td rowspan="1" colspan="1">rs28757190</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Austrian women (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)<break/>Japanese women (79, 59) (<xref ref-type="bibr" rid="DMN040C118">Tsuchiya <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>GSTM1</italic> (1p13.3, glutathione-<italic>S</italic>-transferase M1: phase II detoxification)</td><td rowspan="1" colspan="1">Null deletion</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">French women (50, 72) (<xref ref-type="bibr" rid="DMN040C10">Baranova <italic>et al</italic>., 1997</xref>); (65, 72) (<xref ref-type="bibr" rid="DMN040C11">Baranova <italic>et al</italic>., 1999</xref>)<break/>Russian women - in combination with either GSTT1 null mutation homozygots or NAT2 slow acetylator (*5, *6, *7 homozygots) (74, 40) (<xref ref-type="bibr" rid="DMN040C69">Ivashchenko <italic>et al</italic>., 2003</xref>)<break/>Chinese women (76, 80) (<xref ref-type="bibr" rid="DMN040C101">Peng <italic>et al</italic>., 2003b</xref>)<break/>Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C50">Hsieh <italic>et al</italic>., 2004a</xref>)<break/>South Indian women (310, 215) (<xref ref-type="bibr" rid="DMN040C9">Babu <italic>et al</italic>., 2005</xref>)<break/>Greek women; in combination with CYP1A1 6235T/C (5<sup>&#x02020;</sup>, 54) (<xref ref-type="bibr" rid="DMN040C4">Arvanitis <italic>et al</italic>., 2001</xref>); (275, 346)<break/>(<xref ref-type="bibr" rid="DMN040C5">Arvanitis <italic>et al</italic>., 2003</xref>; Cretan Greek women)<break/>UK, mainly Caucasian women; in combination with CYP1A1 6235T/C (101; 154 + 192 in sib pair analysis) (<xref ref-type="bibr" rid="DMN040C42">Hadfield <italic>et al</italic>., 2001</xref>)</td><td rowspan="1" colspan="1">Australian women (84, 219) (<xref ref-type="bibr" rid="DMN040C12">Baxter <italic>et al</italic>., 2001</xref>)<break/>Japanese women (35, 37) (<xref ref-type="bibr" rid="DMN040C65">Iizuka <italic>et al</italic>., 2003</xref>);<break/>(114, 179) (<xref ref-type="bibr" rid="DMN040C95">Morizane <italic>et al</italic>., 2004</xref>)<break/>Korean women (194, 259) (<xref ref-type="bibr" rid="DMN040C64">Hur <italic>et al</italic>., 2005</xref>)<break/>Korean women (316, 256) (<xref ref-type="bibr" rid="DMN040C78">Kim <italic>et al</italic>., 2007b</xref>)</td><td rowspan="1" colspan="1">Australian women (84, 219) (<xref ref-type="bibr" rid="DMN040C12">Baxter <italic>et al</italic>., 2001</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>GSTP1</italic> (11q13, glutathione-<italic>S</italic>-transferase P1: phase II detoxification)</td><td rowspan="1" colspan="1">p.I105V</td><td rowspan="1" colspan="1">rs1695</td><td rowspan="1" colspan="1">Turkish women (150, 150) (<xref ref-type="bibr" rid="DMN040C29">Ertunc <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1">Korean women (194, 259) (<xref ref-type="bibr" rid="DMN040C64">Hur <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>GSTT1</italic> (22q11.23, glutathione-<italic>S</italic>-transferase T1: phase II detoxification)</td><td rowspan="1" colspan="1">Null deletion</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women, in association with AHRR p.A185P (316, 256) (<xref ref-type="bibr" rid="DMN040C78">Kim <italic>et al</italic>., 2007b</xref>)<break/>Russian women; in combination with either GSTM1 null mutation homozygots or NAT2 slow acetylator (*5, *6, *7 homozygots) (74, 40) (<xref ref-type="bibr" rid="DMN040C69">Ivashchenko <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1">French women (65, 72) (<xref ref-type="bibr" rid="DMN040C11">Baranova <italic>et al</italic>., 1999</xref>)<break/>Greek women (275, 346) (<xref ref-type="bibr" rid="DMN040C5">Arvanitis <italic>et al</italic>., 2003</xref>)<break/>South Indian women (310, 215) (<xref ref-type="bibr" rid="DMN040C9">Babu <italic>et al</italic>., 2005</xref>)<break/>Korean women (194, 259) (<xref ref-type="bibr" rid="DMN040C64">Hur <italic>et al</italic>., 2005</xref>); no association)<break/>Japanese women (114, 179) (<xref ref-type="bibr" rid="DMN040C95">Morizane <italic>et al</italic>., 2004</xref>)<break/>UK, mainly Caucasian women (129, 147) (<xref ref-type="bibr" rid="DMN040C42">Hadfield <italic>et al</italic>., 2001</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>HSD17B1</italic> (17q11-q21, 5 17-&#x003b2; hydroxysteroid dehydrogenase: testosterone biosynthesis, Estrogen metabolism)</td><td rowspan="1" colspan="1">&#x02212;27A/C (vIV)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Austrian women (32, 790) (<xref ref-type="bibr" rid="DMN040C63">Huber <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.S312G</td><td rowspan="1" colspan="1">rs605059</td><td rowspan="1" colspan="1">Japanese women (79, 59) (<xref ref-type="bibr" rid="DMN040C118">Tsuchiya <italic>et al</italic>., 2005b</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women; disease severity (<xref ref-type="bibr" rid="DMN040C118">Tsuchiya <italic>et al</italic>., 2005b</xref>)</td></tr><tr><td rowspan="1" colspan="1"><italic>MPO</italic> (17q23.1, myeloperoxidase: phase I detoxification, oxidation and activation of carcinogens and nitric oxide)</td><td rowspan="1" colspan="1">&#x02212;463G/A</td><td rowspan="1" colspan="1">rs2333227</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C50">Hsieh <italic>et al</italic>., 2004a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>NAT1</italic> (8p23.1-p21.3, <italic>N</italic>-acetyltransferase 1: phase II detoxification)</td><td rowspan="1" colspan="1">NAT1*3, *4, *10, *11</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Japanese women (145, 182) (<xref ref-type="bibr" rid="DMN040C25">Deguchi <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>NAT2</italic> (8p22, <italic>N</italic>-acetyltransferase 2: phase II detoxification)</td><td rowspan="1" colspan="1">Nat2*4-*7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">French women NAT2*5 allele (65, 72) (<xref ref-type="bibr" rid="DMN040C11">Baranova <italic>et al</italic>., 1999</xref>)<break/>UK women NAT2*4/NAT2*6 genotype (54, 123) (<xref ref-type="bibr" rid="DMN040C97">Nakago <italic>et al</italic>., 2001</xref>)<break/>Balkan women NAT2*7 allele (102, 153) (<xref ref-type="bibr" rid="DMN040C68">Iskhakova, 2006</xref>)<break/>Russian women; slow acetylator (*5, *6, *7 homozygots) in combination with either GSTT1 or GSTM1 null mutation homozygots (74, 40) (<xref ref-type="bibr" rid="DMN040C69">Ivashchenko <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1">South Indian women (252, 264) (<xref ref-type="bibr" rid="DMN040C8">Babu <italic>et al</italic>., 2004</xref>)<break/>Japanese women (145, 182) (<xref ref-type="bibr" rid="DMN040C25">Deguchi <italic>et al</italic>., 2005</xref>); (35, 37) (<xref ref-type="bibr" rid="DMN040C65">Iizuka <italic>et al</italic>., 2003</xref>)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Genes are grouped alphabetically, and studies showing positive or negative associations of these genes with disease susceptibility and/or positive associations with phenotype are presented. <sup>&#x02020;</sup>Affected family members.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4d"><title>Genes regulating vascular function and tissue remodelling</title><p>Endometriosis shows some of the characteristics typically seen in malignant cells, such as neovascularization and local invasion (<xref ref-type="bibr" rid="DMN040C56">Hsieh <italic>et al</italic>., 2005c</xref>). Therefore, polymorphisms in a number of genes involved in vascular and cellular growth and reorganization have been investigated for a possible role in endometriosis.</p><sec id="s4d1"><title>Vascular endothelial growth factor, epidermal growth factor receptor and endostatin</title><p>Vascular endothelial growth factor (VEGF) mediates vascular permeability and angiogenesis, and is known to be a key molecule in the pathogenesis of endometriosis (<xref ref-type="bibr" rid="DMN040C14">Bhanoori <italic>et al</italic>., 2005a</xref>; <xref ref-type="bibr" rid="DMN040C75">Kim <italic>et al</italic>., 2005a</xref>). Three polymorphisms in the <italic>VEGF</italic> gene have been evaluated in women with endometriosis. The 405G/C polymorphism has been linked to endometriosis susceptibility in South Indian women, and with susceptibility to advanced-stage endometriosis in Korean women (<xref ref-type="bibr" rid="DMN040C14">Bhanoori <italic>et al</italic>., 2005a</xref>; <xref ref-type="bibr" rid="DMN040C75">Kim <italic>et al</italic>., 2005a</xref>). In contrast, the &#x02212;460C/T polymorphism did not appear to affect susceptibility in either of these populations (<xref ref-type="bibr" rid="DMN040C14">Bhanoori <italic>et al</italic>., 2005a</xref>; <xref ref-type="bibr" rid="DMN040C75">Kim <italic>et al</italic>., 2005a</xref>), but may influence the risk of endometriosis in Taiwanese women (<xref ref-type="bibr" rid="DMN040C53">Hsieh <italic>et al</italic>., 2004d</xref>). The <italic>VEGF</italic> 936C/T polymorphism and the endostatin 4349G/A polymorphism were not associated with endometriosis in Korean women (<xref ref-type="bibr" rid="DMN040C77">Kim <italic>et al</italic>., 2007a</xref>) (Table&#x000a0;<xref ref-type="table" rid="DMN040TB4">IV</xref>). The epidermal growth factor receptor (EGFR) is another molecule involved in angiogenesis, and the <italic>EGFR</italic> 2073*T allele has been linked to an increased risk of endometriosis in Taiwanese women (<xref ref-type="bibr" rid="DMN040C58">Hsieh <italic>et al</italic>., 2005e</xref>) (Table&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>).</p><table-wrap id="DMN040TB4" position="float"><label>Table IV</label><caption><p>Polymorphisms encoding genes involved in glucose homeostasis, vascular function and tissue remodelling, which have been investigated for their role in endometriosis</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene (locus, protein name and its function)</th><th align="left" colspan="2" rowspan="1">Variant<hr/></th><th align="left" colspan="2" rowspan="1">Association with susceptibility<hr/></th><th align="left" rowspan="1" colspan="1">Phenotype</th></tr><tr><th align="left" rowspan="1" colspan="1">Name</th><th align="left" rowspan="1" colspan="1">dbSNP ID</th><th align="left" rowspan="1" colspan="1">Positive</th><th align="left" rowspan="1" colspan="1">Negative</th></tr></thead><tbody><tr><td colspan="6" rowspan="1">Mediators of glucose homeostasis</td></tr><tr><td rowspan="1" colspan="1"><italic>GALT</italic> (9p13, galactose-1-phosphate uridyl transferase: galactose metabolism)</td><td rowspan="1" colspan="1">p.N314D</td><td rowspan="1" colspan="1">rs2070074</td><td rowspan="1" colspan="1">North American women (33, 111) (<xref ref-type="bibr" rid="DMN040C21">Cramer <italic>et al</italic>., 1996</xref>)</td><td rowspan="1" colspan="1">UK women (148, 148) (<xref ref-type="bibr" rid="DMN040C41">Hadfield <italic>et al</italic>., 1999</xref>); (78, 248 C) (<xref ref-type="bibr" rid="DMN040C96">Morland <italic>et al</italic>., 1998</xref>)<break/>Icelandic women (85 cases, 103 male controls, 110 female controls) (<xref ref-type="bibr" rid="DMN040C108">Stefansson <italic>et al</italic>., 2001</xref>)<break/>Chinese women (325, 310) (<xref ref-type="bibr" rid="DMN040C44">He <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.Q188R</td><td rowspan="1" colspan="1">No dbSNP ID (rare mutation)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Chinese women (325, 310) (<xref ref-type="bibr" rid="DMN040C44">He <italic>et al</italic>., 2006</xref>)<break/>UK women (78, 248) (<xref ref-type="bibr" rid="DMN040C96">Morland <italic>et al</italic>., 1998</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>PPARG</italic> (3p25, peroxisome proliferator-activated receptor-&#x003b3;: transcription factor; mediates insulin resistance, regulates <italic>CCL5</italic> expression)</td><td rowspan="1" colspan="1">p.P12A</td><td rowspan="1" colspan="1">rs1801282</td><td rowspan="1" colspan="1">German women (51, 55) (<xref ref-type="bibr" rid="DMN040C27">Dogan <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1">Japanese women (390 women with endometriosis, leiomyoma or adenomyoma, 144 controls) (<xref ref-type="bibr" rid="DMN040C83">Kiyomizu <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.H447H, 161C/T</td><td rowspan="1" colspan="1">rs3856806</td><td rowspan="1" colspan="1">Japanese women (390 women with EM, leiomyoma or adenomyoma, 144 controls) (<xref ref-type="bibr" rid="DMN040C83">Kiyomizu <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Mediators of vascular function or genes linked to cardiovascular risk</td></tr><tr><td rowspan="1" colspan="1"><italic>ACE</italic> (17q23.3, angiotensin-I converting enzyme: mediates vascular homeostasis)</td><td rowspan="1" colspan="1">&#x02212;240A/T</td><td rowspan="1" colspan="1">rs4291</td><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C54">Hsieh <italic>et al</italic>., 2005a</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2350A/G</td><td rowspan="1" colspan="1">rs4343</td><td rowspan="1" colspan="1">Taiwanese women (150, 159) (<xref ref-type="bibr" rid="DMN040C54">Hsieh <italic>et al</italic>., 2005a</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">287 bp ALU ins/del in intron 16</td><td rowspan="1" colspan="1">Several dbSNP IDs: rs4646994 or rs4340, rs1799752</td><td rowspan="1" colspan="1">Taiwanese women (125 endometriosis, 120 leiomyoma, 128 control) (<xref ref-type="bibr" rid="DMN040C61">Hsieh <italic>et al</italic>., 2007a</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>COL18A1</italic> (21q22.3, endostatin: inhibits endothelial cell proliferation and angiogenesis)</td><td rowspan="1" colspan="1">4349G/A (p.D1437 N) (p.D104 N)</td><td rowspan="1" colspan="1">rs12483377</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women (105, 100 + 100) (<xref ref-type="bibr" rid="DMN040C77">Kim <italic>et al</italic>., 2007a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>VEGFA</italic> (6p12, vascular endothelial growth factor: mediates vascular permeability and angiogenesis)</td><td rowspan="1" colspan="1">405G/C (&#x02212;634G/C)</td><td rowspan="1" colspan="1">Rs2010963</td><td rowspan="1" colspan="1">South Indian women (215, 210) (<xref ref-type="bibr" rid="DMN040C14">Bhanoori <italic>et al</italic>., 2005a</xref>)<break/>Korean women (215, 219 + 70) (<xref ref-type="bibr" rid="DMN040C75">Kim <italic>et al</italic>., 2005a</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;460C/T</td><td rowspan="1" colspan="1">Rs833061</td><td rowspan="1" colspan="1">Taiwanese women (122, 131) (<xref ref-type="bibr" rid="DMN040C53">Hsieh <italic>et al</italic>., 2004d</xref>)</td><td rowspan="1" colspan="1">South Indian women (215, 210) (<xref ref-type="bibr" rid="DMN040C14">Bhanoori <italic>et al</italic>., 2005a</xref>)<break/>Korean women (215, 219 + 70) (<xref ref-type="bibr" rid="DMN040C75">Kim <italic>et al</italic>., 2005a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">936C/T</td><td rowspan="1" colspan="1">rs3025039</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Korean women (105, 100 + 100) (<xref ref-type="bibr" rid="DMN040C77">Kim <italic>et al</italic>., 2007a</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Genes involved in tissue remodelling</td></tr><tr><td rowspan="1" colspan="1"><italic>AHSG</italic> (3q27, alpha 2-Heremans Schmidt glycoprotein: mediates tissue development)</td><td rowspan="1" colspan="1">p.T230M</td><td rowspan="1" colspan="1">rs4917</td><td rowspan="1" colspan="1">Korean women (79, 105) (<xref ref-type="bibr" rid="DMN040C74">Kim <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">p.T238S</td><td rowspan="1" colspan="1">rs4918</td><td rowspan="1" colspan="1">Korean women (79, 105) (<xref ref-type="bibr" rid="DMN040C74">Kim <italic>et al</italic>., 2004</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>MMP1</italic> (11q22.3, matrix metalloproteinase-1: tissue remodelling)</td><td rowspan="1" colspan="1">&#x02212;1607ins/delG (1G/2G)</td><td rowspan="1" colspan="1">rs112925</td><td rowspan="1" colspan="1">Chinese women: 2G allele (100, 150) (<xref ref-type="bibr" rid="DMN040C72">Kang <italic>et al</italic>., 2005</xref>)<break/>North China population (100,150) (<xref ref-type="bibr" rid="DMN040C104">Shan <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1">Italian women (56, 71) (<xref ref-type="bibr" rid="DMN040C33">Ferrari <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>MMP3</italic> (11q22.3, matrix metalloproteinase-3: tissue remodelling)</td><td rowspan="1" colspan="1">&#x02212;1171ins/delA (5A/6A)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Chinese women MMP1-2G MMP3-6A haplotype (100, 150) (<xref ref-type="bibr" rid="DMN040C72">Kang <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C104">Shan <italic>et al</italic>., 2005</xref>)</td><td rowspan="1" colspan="1">Chinese women (100, 150) (<xref ref-type="bibr" rid="DMN040C72">Kang <italic>et al</italic>., 2005</xref>)<break/>North China population (100,150) (<xref ref-type="bibr" rid="DMN040C104">Shan <italic>et al</italic>., 2005</xref>)<break/>Italian women (56, 71) (<xref ref-type="bibr" rid="DMN040C33">Ferrari <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>MMP7</italic> (11q21-q22, matrix metalloproteinase-7: tissue remodelling)</td><td rowspan="1" colspan="1">&#x02212;181A/G</td><td rowspan="1" colspan="1">rs1799750</td><td rowspan="1" colspan="1">Chinese women (143 EM, 76 AM, 160) (<xref ref-type="bibr" rid="DMN040C105">Shan <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>MMP9</italic> (20q11.2-q13.1, matrix metalloproteinase-9: tissue remodelling)</td><td rowspan="1" colspan="1">&#x02212;1562C/T</td><td rowspan="1" colspan="1">rs3918242</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Chinese women (143 EM, 76 AM) (<xref ref-type="bibr" rid="DMN040C105">Shan <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>SERPINE1</italic> (7q21.3&#x02013;q22, plasminogen activator inhibitor-1: fibrinolysis system.<break/>Linked to cardiovascular disease)</td><td rowspan="1" colspan="1">&#x02212;675ins/delG (4G/5G)</td><td rowspan="1" colspan="1">Several dbSNP IDs: rs1799768, rs34857375, rs1799762, rs1799889</td><td rowspan="1" colspan="1">Canadian and North American women (75, 43) (<xref ref-type="bibr" rid="DMN040C13">Bedaiwy <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Genes involved in signal transduction</td></tr><tr><td rowspan="1" colspan="1"><italic>EMX2</italic> (10q26.1, empty spiracles homeobox 2: homeodomain transcription factor)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs1860399, rs82 613, rs82 612, rs242956, rs703409, rs703411, rs1638626, rs2286629, rs385209, rs855769, rs365446, rs8192640, rs740734, rs855768, rs2240776, rs703413, rs4751627, rs242960, rs8181280, rs855766, rs4752078, rs4752079</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Australian women 768, 768) (<xref ref-type="bibr" rid="DMN040C116">Treloar <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>STAT6</italic> (12q13, signal transducer and activator of transcription 6: signal transduction and activation of transcription)</td><td rowspan="1" colspan="1">2964G/A</td><td rowspan="1" colspan="1">rs324015</td><td rowspan="1" colspan="1">South Indian women (232, 210) (<xref ref-type="bibr" rid="DMN040C16">Bhanoori <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Genes involved in malignant transformation</td></tr><tr><td rowspan="1" colspan="1"><italic>KRAS</italic> (12p12.1, kirsten rat sarcoma viral oncogene homologue: proto-oncogene)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs7304896, rs7132980, rs4556643, rs11612828, rs12320328, rs11047921, rs11047919, rs7309670, rs17388893, rs10842514, rs6487464, rs4495968, rs17388587, rs11047912, rs17329025, rs17388148, rs11047901, rs12579073, rs12313763, rs1137282, rs9266, rs13096, rs11047892, rs4963857, rs7137734, rs11047889, rs11047887, rs11609324, rs11836162, rs3924649</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Australian women (959, 959) (<xref ref-type="bibr" rid="DMN040C140">Zhao <italic>et al</italic>., 2006</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>PTEN</italic> (10q23.3, phosphate and tensin homologue: tumour suppressor)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs2673836, rs1234220, rs1234219, rs1903858, rs2299939, rs11202597, rs1234224, rs2735343, rs17431184, rs555895, rs2736627, rs926091, rs532678, rs701848, rs478839</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Australian women (768, 768) (<xref ref-type="bibr" rid="DMN040C116">Treloar <italic>et al</italic>., 2007</xref>)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Genes are grouped according to their function and then alphabetically, and studies showing positive or negative associations of these genes with disease susceptibility and/or positive associations with phenotype are presented.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4d2"><title>Angiotensin-I-converting enzyme</title><p>Angiotensin-I-converting enzyme (ACE) catalyzes the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Three polymorphisms in the gene encoding this enzyme have been investigated in Taiwanese women with endometriosis, and both the 2350A/G and &#x02212;240A/T variants as well as the insertion/deletion (I/D) polymorphism are associated with endometriosis susceptibility in this population (<xref ref-type="bibr" rid="DMN040C54">Hsieh <italic>et al</italic>., 2005a</xref>, <xref ref-type="bibr" rid="DMN040C61">2007a</xref>).</p></sec><sec id="s4d3"><title>Matrix metalloproteinases</title><p>Matrix metalloproteinases (MMPs) are thought to be involved in the tissue invasion that occurs during endometriotic lesion formation (<xref ref-type="bibr" rid="DMN040C33">Ferrari <italic>et al</italic>., 2006</xref>). Polymorphisms in <italic>MMP1</italic>, <italic>MMP3</italic>, <italic>MMP7</italic> and <italic>MMP9</italic> genes have been investigated in Chinese women with endometriosis. A single I/D polymorphism 1G/2G (also referred to as &#x02212;1607ins/delG) in the promoter region of the <italic>MMP1</italic> gene and the &#x02212;181A/G polymorphism in the <italic>MMP7</italic> gene were associated with an increased risk of endometriosis (<xref ref-type="bibr" rid="DMN040C72">Kang <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C105">Shan <italic>et al</italic>., 2006</xref>). In contrast, a single I/D polymorphism &#x02212;1171ins/delA (5A/6A) in the promoter region of the <italic>MMP3</italic> gene did not appear to affect endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C72">Kang <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C104">Shan <italic>et al</italic>., 2005</xref>). The <italic>MMP1(2G)/MMP3(6A)</italic> combination showed an association (<xref ref-type="bibr" rid="DMN040C72">Kang <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C104">Shan <italic>et al</italic>., 2005</xref>), but this is probably due to the effects of the <italic>MMP1</italic> (2G) genotype rather than a combined effect of both genes. The &#x02212;1562C/T polymorphism in the <italic>MMP9</italic> gene was not associated with endometriosis susceptibility (<xref ref-type="bibr" rid="DMN040C105">Shan <italic>et al</italic>., 2006</xref>). A group that investigated MMP polymorphisms in a population of Italian women found no association between <italic>MMP1</italic> or <italic>MMP3</italic> gene polymorphisms and susceptibility to endometriosis (<xref ref-type="bibr" rid="DMN040C33">Ferrari <italic>et al</italic>., 2006</xref>).</p></sec><sec id="s4d4"><title>&#x003b1;2-HS glycoprotein, plasminogen activator inhibitor-1</title><p>&#x003b1;2-HS glycoprotein (AHSG) has been implicated in tissue development, and polymorphisms in the <italic>AHSG</italic> gene (p.T230M and p.T238S) have been linked to endometriosis susceptibility in Korean women (<xref ref-type="bibr" rid="DMN040C74">Kim <italic>et al</italic>., 2004</xref>). The plasminogen activator inhibitor 1 (PAI-1) 4G/5G promoter polymorphism has been investigated in 75 women with laparoscopically confirmed endometriosis and 43 controls (<xref ref-type="bibr" rid="DMN040C13">Bedaiwy <italic>et al</italic>., 2006</xref>). In this study, the 4G/4G genotype, known to be associated with hypofibrinolysis, was found to be over-represented among women with endometriosis.</p></sec><sec id="s4d5"><title>Summary</title><p>No consistent evidence linking specific polymorphisms of genes endoding proteins involved in vascular function and tissue remodelling with endometriosis is available. A number of polymorphisms have been found to be associated with endometriosis in selected populations (Table&#x000a0;<xref ref-type="table" rid="DMN040TB4">IV</xref>). These associations, however, have not been independently confirmed across ethnic barriers either because only single studies are available or because other studies investigating these polymorphisms reported no association. No meta-analysis of respective studies has been published. Therefore, no specific polymorphisms of genes encoding proteins involved in vascular function and tissue remodelling have been convincingly shown to play a role in the susceptibility to endometriosis.</p></sec></sec><sec id="s4e"><title>Other genes linked to endometriosis</title><p>Genes involved in signal transduction (<italic>STAT6</italic>, Table&#x000a0;<xref ref-type="table" rid="DMN040TB4">IV</xref>), malignant transformation (<italic>TP53</italic>, <italic>P21</italic>, <italic>KRAS</italic>, Table&#x000a0;<xref ref-type="table" rid="DMN040TB4">IV</xref>; <italic>BRAF</italic>), apoptosis (<italic>FAS</italic>, Table&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>; <italic>FASLG</italic>, Table&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>) and galactose metabolism (<italic>GAL T</italic>,Table&#x000a0;<xref ref-type="table" rid="DMN040TB4">IV</xref>) have been investigated for a role in endometriosis susceptibility, but no consistent association has been found (Tables&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>&#x02013;<xref ref-type="table" rid="DMN040TB4">IV</xref>) (<xref ref-type="bibr" rid="DMN040C21">Cramer <italic>et al</italic>., 1996</xref>; <xref ref-type="bibr" rid="DMN040C96">Morland <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="DMN040C41">Hadfield <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="DMN040C47">Hsieh <italic>et al</italic>., 2001c</xref>; <xref ref-type="bibr" rid="DMN040C108">Stefansson <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="DMN040C19">Chang <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="DMN040C85">Lattuada <italic>et al</italic>., 2004b</xref>; <xref ref-type="bibr" rid="DMN040C98">Omori <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="DMN040C32">Fernandez <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="DMN040C44">He <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="DMN040C60">Hsieh and Lin, 2006</xref>; <xref ref-type="bibr" rid="DMN040C140">Zhao <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="DMN040C16">Bhanoori <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="DMN040C121">Vietri <italic>et al</italic>., 2007</xref>). Two exceptions are the <italic>STAT6</italic> 3&#x02032;-UTR 2964G/A polymorphism (<xref ref-type="bibr" rid="DMN040C16">Bhanoori <italic>et al</italic>., 2007</xref>) and the <italic>GALT</italic> p.N314D polymorphism (<xref ref-type="bibr" rid="DMN040C21">Cramer <italic>et al</italic>., 1996</xref>), which are over-represented among South Indian women and US women with endometriosis, respectively. <xref ref-type="bibr" rid="DMN040C60">Hsieh and Lin (2006)</xref> found that the <italic>TP53</italic> codon p.R72P polymorphism was associated with endometriosis in Taiwanese women and also looked for the presence of mutations at codons 11 and 248 in this population, but did not find any (Table&#x000a0;<xref ref-type="table" rid="DMN040TB1">I</xref>). An Australian study of 22 polymorphisms in the <italic>EMX2</italic> gene and 15 polymorphisms in the <italic>PTEN</italic> gene found no association with endometriosis (<xref ref-type="bibr" rid="DMN040C116">Treloar <italic>et al</italic>., 2007</xref>).</p><sec id="s4e1"><title>Summary</title><p>No consistent and independently confirmed evidence linking specific polymorphisms of the <italic>STAT6, TP53, P21, FAS, FASLG, EMX2, PTEN, CTLA4</italic> and <italic>GALT</italic> genes is available.</p></sec></sec></sec><sec sec-type="" id="s5"><title>Discussion</title><p>In this review, we have summarized the current evidence linking genetic polymorphisms and endometriosis, showing that the majority of polymorphisms investigated so far are not associated with this disease in a methodologically reliable way. This may be because they have been investigated in only a single study or a limited number of studies, or because conflicting results were obtained.</p><p>The most solid evidence to date linking specific polymorphisms to endometriosis comes from studies investigating phase II detoxification enzymes. A systematic review and meta-analysis of studies investigating the glutathione-<italic>S</italic>-transferases <italic>GSTM1</italic> and <italic>GSTT1</italic> variants demonstrated a consistent association of a <italic>GSTT1</italic> polymorphism and endometriosis, with a 29% increased risk of endometriosis in <italic>GSTT1</italic> null deletion carriers.</p><p>There is no consistent evidence to link specific polymorphisms of genes encoding inflammatory mediators and proteins involved in sex steroid metabolism, vascular function and tissue remodelling with endometriosis. Although a number of polymorphisms have been found associated with endometriosis in selected populations, these associations have not been independently confirmed across ethnic barriers, either because only single studies are available or because other studies reported no association. The majority of polymorphisms have not been subjected to meta-analysis due to the limited availability of comparable studies. However, a systematic review and meta-analysis of sex steroid biosynthesis and sex steroid receptors demonstrated no consistent association of the investigated polymorphisms with endometriosis.</p><p>Clearly, absence of evidence of an association between a specific polymorphism and endometriosis does not rule out that this gene in general or other polymorphisms of this gene in particular may be involved in the etiology of this disease.</p><p>To date, most studies are retrospective genetic association studies, whereas others are studies with prospectively identified cases. This is a potential source of inconsistency, since studies including prospectively identified cases, i.e. incident cases, may produce different results compared with studies using retrospectively identified cases, i.e. prevalent cases. Other problems facing researchers in this field are well-illustrated in two recent reviews on the genetics of endometriosis (<xref ref-type="bibr" rid="DMN040C39">Guo, 2006a</xref>, <xref ref-type="bibr" rid="DMN040C40">b</xref>). The author ruled out many of the previous positive findings, highlighting issues such as lack of independent confirmation for many studies (<xref ref-type="bibr" rid="DMN040C40">Guo, 2006b</xref>) and faulty analyses (<xref ref-type="bibr" rid="DMN040C39">Guo, 2006a</xref>).</p><p>In order to further explore the importance of known and new polymorphisms in female reproductive function, it is essential that studies are well-designed and sufficiently powered. Whereas retrospective studies are useful for generating hypotheses, a prospective design must be used to test these hypotheses. Exploratory (hypothesis-generating) studies should aim to screen large numbers of genetic variations. This becomes an option for more researchers as high-throughput genotyping technologies improve and become more widely accessible. The exploratory phase should be followed by validation of a limited number of candidate markers (hypothesis testing), and prospective studies should be conducted whenever an association is confirmed. This approach will allow the identification and validation of polymorphisms, and those with strong links to susceptibility may help in developing new drugs or regimens. In addition, the discovery of genes that influence treatment response may enable individualized treatment to be tailored on the basis of genotype.</p></sec><sec sec-type="" id="s6"><title>Funding</title><p>The preparation of this manuscript was sponsored by an unrestricted educational grant from <funding-source>Merck Serono</funding-source>, Geneva, Switzerland.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thanks Drs Polly Field, Imogen Horsey and Kay Elder for their assistance in drafting the manuscript.</p></ack><ref-list><title>References</title><ref id="DMN040C1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agic</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Finas</surname><given-names>D</given-names></name><name><surname>Banz</surname><given-names>C</given-names></name><name><surname>Diedrich</surname><given-names>K</given-names></name><name><surname>Hornung</surname><given-names>D</given-names></name></person-group><article-title>Is endometriosis associated with systemic subclinical inflammation?</article-title><source>Gynecol Obstet Invest</source><year>2006</year><volume>62</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">16679772</pub-id></element-citation></ref><ref id="DMN040C2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinolo</surname><given-names>G</given-names></name><name><surname>Fernandez</surname><given-names>RM</given-names></name><name><surname>Noval</surname><given-names>JA</given-names></name><name><surname>Garcia-Lozano</surname><given-names>JC</given-names></name><name><surname>Borrego</surname><given-names>S</given-names></name><name><surname>Marcos</surname><given-names>I</given-names></name><name><surname>Molini</surname><given-names>JL</given-names></name></person-group><article-title>Evaluation of germline sequence variants within the promoter region of RANTES gene in a cohort of women with endometriosis from Spain</article-title><source>Mol Hum Reprod</source><year>2003</year><volume>9</volume><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">12837926</pub-id></element-citation></ref><ref id="DMN040C3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinolo</surname><given-names>G</given-names></name><name><surname>Fernandez</surname><given-names>RM</given-names></name><name><surname>Noval</surname><given-names>JA</given-names></name><name><surname>Molini</surname><given-names>JL</given-names></name><name><surname>Borrego</surname><given-names>S</given-names></name></person-group><article-title>Analysis of the involvement of CCR5-Delta32 and CCR2-V64I variants in the development of endometriosis</article-title><source>Mol Hum Reprod</source><year>2004</year><volume>10</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">14981141</pub-id></element-citation></ref><ref id="DMN040C4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvanitis</surname><given-names>DA</given-names></name><name><surname>Goumenou</surname><given-names>AG</given-names></name><name><surname>Matalliotakis</surname><given-names>IM</given-names></name><name><surname>Koumantakis</surname><given-names>EE</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name></person-group><article-title>Low-penetrance genes are associated with increased susceptibility to endometriosis</article-title><source>Fertil Steril</source><year>2001</year><volume>76</volume><fpage>1202</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">11730751</pub-id></element-citation></ref><ref id="DMN040C5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvanitis</surname><given-names>DA</given-names></name><name><surname>Koumantakis</surname><given-names>GE</given-names></name><name><surname>Goumenou</surname><given-names>AG</given-names></name><name><surname>Matalliotakis</surname><given-names>IM</given-names></name><name><surname>Koumantakis</surname><given-names>EE</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name></person-group><article-title>CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis</article-title><source>Fertil Steril</source><year>2003</year><volume>79</volume><issue>Suppl 1</issue><fpage>702</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">12620480</pub-id></element-citation></ref><ref id="DMN040C6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asghar</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Negoro</surname><given-names>K</given-names></name><name><surname>Zhuo</surname><given-names>W</given-names></name><name><surname>Hamana</surname><given-names>S</given-names></name><name><surname>Motoyama</surname><given-names>S</given-names></name><name><surname>Nakago</surname><given-names>S</given-names></name><name><surname>Barlow</surname><given-names>D</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>The tumor necrosis factor-alpha promoter&#x02014;1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population</article-title><source>Hum Reprod</source><year>2004</year><volume>19</volume><fpage>2509</fpage><lpage>2514</lpage><pub-id pub-id-type="pmid">15319381</pub-id></element-citation></ref><ref id="DMN040C7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asghar</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Nakago</surname><given-names>S</given-names></name><name><surname>Morizane</surname><given-names>M</given-names></name><name><surname>Ohara</surname><given-names>N</given-names></name><name><surname>Motoyama</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Barlow</surname><given-names>D</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations</article-title><source>Gynecol Endocrinol</source><year>2005</year><volume>20</volume><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15823822</pub-id></element-citation></ref><ref id="DMN040C8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>KA</given-names></name><name><surname>Rao</surname><given-names>KL</given-names></name><name><surname>Reddy</surname><given-names>NG</given-names></name><name><surname>Kanakavalli</surname><given-names>MK</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Deenadayal</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Shivaji</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name></person-group><article-title><italic>N</italic>-acetyl transferase 2 polymorphism and advanced stages of endometriosis in South Indian women</article-title><source>Reprod Biomed Online</source><year>2004</year><volume>9</volume><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">15588473</pub-id></element-citation></ref><ref id="DMN040C9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>KA</given-names></name><name><surname>Reddy</surname><given-names>NG</given-names></name><name><surname>Deendayal</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Shivaji</surname><given-names>S</given-names></name></person-group><article-title>GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women</article-title><source>Pharmacogenet Genomics</source><year>2005</year><volume>15</volume><fpage>167</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">15861041</pub-id></element-citation></ref><ref id="DMN040C10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baranova</surname><given-names>H</given-names></name><name><surname>Bothorishvilli</surname><given-names>R</given-names></name><name><surname>Canis</surname><given-names>M</given-names></name><name><surname>Albuisson</surname><given-names>E</given-names></name><name><surname>Perriot</surname><given-names>S</given-names></name><name><surname>Glowaczower</surname><given-names>E</given-names></name><name><surname>Bruhat</surname><given-names>MA</given-names></name><name><surname>Baranov</surname><given-names>V</given-names></name><name><surname>Malet</surname><given-names>P</given-names></name></person-group><article-title>Glutathione <italic>S</italic>-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population</article-title><source>Mol Hum Reprod</source><year>1997</year><volume>3</volume><fpage>775</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">9358003</pub-id></element-citation></ref><ref id="DMN040C11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baranova</surname><given-names>H</given-names></name><name><surname>Canis</surname><given-names>M</given-names></name><name><surname>Ivaschenko</surname><given-names>T</given-names></name><name><surname>Albuisson</surname><given-names>E</given-names></name><name><surname>Bothorishvilli</surname><given-names>R</given-names></name><name><surname>Baranov</surname><given-names>V</given-names></name><name><surname>Malet</surname><given-names>P</given-names></name><name><surname>Bruhat</surname><given-names>MA</given-names></name></person-group><article-title>Possible involvement of arylamine <italic>N</italic>-acetyltransferase 2, glutathione <italic>S</italic>-transferases M1 and T1 genes in the development of endometriosis</article-title><source>Mol Hum Reprod</source><year>1999</year><volume>5</volume><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">10381818</pub-id></element-citation></ref><ref id="DMN040C12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxter</surname><given-names>SW</given-names></name><name><surname>Thomas</surname><given-names>EJ</given-names></name><name><surname>Campbell</surname><given-names>IG</given-names></name></person-group><article-title>GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer</article-title><source>Carcinogenesis</source><year>2001</year><volume>22</volume><fpage>63</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">11159742</pub-id></element-citation></ref><ref id="DMN040C13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedaiwy</surname><given-names>MA</given-names></name><name><surname>Falcone</surname><given-names>T</given-names></name><name><surname>Mascha</surname><given-names>EJ</given-names></name><name><surname>Casper</surname><given-names>RF</given-names></name></person-group><article-title>Genetic polymorphism in the fibrinolytic system and endometriosis</article-title><source>Obstet Gynecol</source><year>2006</year><volume>108</volume><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">16816071</pub-id></element-citation></ref><ref id="DMN040C14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhanoori</surname><given-names>M</given-names></name><name><surname>Arvind</surname><given-names>BK</given-names></name><name><surname>Pavankumar Reddy</surname><given-names>NG</given-names></name><name><surname>Lakshmi</surname><given-names>RK</given-names></name><name><surname>Zondervan</surname><given-names>K</given-names></name><name><surname>Deenadayal</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Shivaji</surname><given-names>S</given-names></name></person-group><article-title>The vascular endothelial growth factor (VEGF) +405G&#x0003e;C 5&#x02032;-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study</article-title><source>Hum Reprod</source><year>2005</year><volume>a 20</volume><fpage>1844</fpage><lpage>1849</lpage><pub-id pub-id-type="pmid">15746194</pub-id></element-citation></ref><ref id="DMN040C15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhanoori</surname><given-names>M</given-names></name><name><surname>Babu</surname><given-names>KA</given-names></name><name><surname>Deenadayal</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Shivaji</surname><given-names>S</given-names></name></person-group><article-title>The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women</article-title><source>J Soc Gynecol Investig</source><year>2005</year><volume>b 12</volume><fpage>365</fpage><lpage>369</lpage></element-citation></ref><ref id="DMN040C16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhanoori</surname><given-names>M</given-names></name><name><surname>Deenadayal</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Shivaji</surname><given-names>S</given-names></name></person-group><article-title>The G2964A 3&#x02032;-untranslated region polymorphism of the signal transducer and activator of transcription 6 gene is associated with endometriosis in South Indian women</article-title><source>Hum Reprod</source><year>2007</year><volume>22</volume><fpage>1026</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">17213269</pub-id></element-citation></ref><ref id="DMN040C17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billington</surname><given-names>BP</given-names></name></person-group><article-title>Gastric cancer; relationships between ABO blood-groups, site, and epidemiology</article-title><source>Lancet</source><year>1956</year><volume>271</volume><fpage>859</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">13368540</pub-id></element-citation></ref><ref id="DMN040C17a"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname><given-names>F</given-names></name><name><surname>Simpson</surname><given-names>JL</given-names></name></person-group><article-title>Genetic basis of endometriosis</article-title><source>Ann NY Acad Sci</source><year>2004</year><volume>1034</volume><fpage>284</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">15731320</pub-id></element-citation></ref><ref id="DMN040C18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero</surname><given-names>V</given-names></name><name><surname>Ruiz</surname><given-names>R</given-names></name><name><surname>Sainz</surname><given-names>JA</given-names></name><name><surname>Cruz</surname><given-names>M</given-names></name><name><surname>Lopez-Nevot</surname><given-names>MA</given-names></name><name><surname>Galan</surname><given-names>JJ</given-names></name><name><surname>Real</surname><given-names>LM</given-names></name><name><surname>de</surname><given-names>CF</given-names></name><name><surname>Lopez-Villaverde</surname><given-names>V</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name></person-group><article-title>Preliminary molecular genetic analysis of the Receptor Interacting Protein 140 (RIP140) in women affected by endometriosis</article-title><source>J Exp Clin Assist Reprod</source><year>2005</year><volume>2</volume><fpage>11</fpage><pub-id pub-id-type="pmid">16131398</pub-id></element-citation></ref><ref id="DMN040C19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>HD</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>The proline form of p53 codon 72 polymorphism is associated with endometriosis</article-title><source>Fertil Steril</source><year>2002</year><volume>77</volume><fpage>43</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">11779589</pub-id></element-citation></ref><ref id="DMN040C20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YJ</given-names></name><name><surname>Hur</surname><given-names>SE</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Song</surname><given-names>IO</given-names></name><name><surname>Moon</surname><given-names>HS</given-names></name><name><surname>Koong</surname><given-names>MK</given-names></name><name><surname>Chung</surname><given-names>HW</given-names></name></person-group><article-title>Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis</article-title><source>J Assist Reprod Genet</source><year>2007</year><volume>24</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">17562158</pub-id></element-citation></ref><ref id="DMN040C21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname><given-names>DW</given-names></name><name><surname>Hornstein</surname><given-names>MD</given-names></name><name><surname>Ng</surname><given-names>WG</given-names></name><name><surname>Barbieri</surname><given-names>RL</given-names></name></person-group><article-title>Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT)</article-title><source>Mol Hum Reprod</source><year>1996</year><volume>2</volume><fpage>149</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">9238674</pub-id></element-citation></ref><ref id="DMN040C22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Amora</surname><given-names>P</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Girao</surname><given-names>MJ</given-names></name><name><surname>Silva</surname><given-names>ID</given-names></name><name><surname>Schor</surname><given-names>E</given-names></name></person-group><article-title>Polymorphisms in exons 1B and 1C of the type I interleukin-1 receptor gene in patients with endometriosis</article-title><source>Am J Reprod Immunol</source><year>2006</year><volume>56</volume><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">16911713</pub-id></element-citation></ref><ref id="DMN040C23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Miretti</surname><given-names>MM</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Ke</surname><given-names>X</given-names></name><name><surname>Monsuur</surname><given-names>AJ</given-names></name><name><surname>Whittaker</surname><given-names>P</given-names></name><name><surname>Delgado</surname><given-names>M</given-names></name><etal/></person-group><article-title>A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>1166</fpage><lpage>1172</lpage><pub-id pub-id-type="pmid">16998491</pub-id></element-citation></ref><ref id="DMN040C24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Carvalho</surname><given-names>CV</given-names></name><name><surname>Nogueira-De-Souza</surname><given-names>NC</given-names></name><name><surname>Costa</surname><given-names>AM</given-names></name><name><surname>Baracat</surname><given-names>EC</given-names></name><name><surname>Girao</surname><given-names>MJ</given-names></name><name><surname>D&#x02019;Amora</surname><given-names>P</given-names></name><name><surname>Schor</surname><given-names>E</given-names></name><name><surname>da</surname><given-names>S</given-names><suffix>I</suffix></name></person-group><article-title>Genetic polymorphisms of cytochrome P450cl7alpha (CYP17) and progesterone receptor genes (PROGINS) in the assessment of endometriosis risk</article-title><source>Gynecol Endocrinol</source><year>2007</year><volume>23</volume><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">17484509</pub-id></element-citation></ref><ref id="DMN040C25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deguchi</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Ohara</surname><given-names>N</given-names></name><name><surname>Motoyama</surname><given-names>S</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>Lack of association between endometriosis and <italic>N</italic>-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population</article-title><source>J Soc Gynecol Investig</source><year>2005</year><volume>12</volume><fpage>208</fpage><lpage>213</lpage></element-citation></ref><ref id="DMN040C26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>SW</given-names></name></person-group><article-title>The search for genetic variants predisposing women to endometriosis</article-title><source>Curr Opin Obstet Gynecol</source><year>2007</year><volume>19</volume><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">17625425</pub-id></element-citation></ref><ref id="DMN040C27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogan</surname><given-names>S</given-names></name><name><surname>Machicao</surname><given-names>F</given-names></name><name><surname>Wallwiener</surname><given-names>D</given-names></name><name><surname>Haering</surname><given-names>HU</given-names></name><name><surname>Diedrich</surname><given-names>K</given-names></name><name><surname>Hornung</surname><given-names>D</given-names></name></person-group><article-title>Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis</article-title><source>Fertil Steril</source><year>2004</year><volume>81</volume><fpage>1411</fpage><lpage>1413</lpage><pub-id pub-id-type="pmid">15136115</pub-id></element-citation></ref><ref id="DMN040C28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Gindi</surname><given-names>E</given-names></name><name><surname>El-Adawy</surname><given-names>AR</given-names></name><name><surname>Faris</surname><given-names>M</given-names></name><name><surname>El-Moghazy</surname><given-names>D</given-names></name><name><surname>El-Hamshary</surname><given-names>M</given-names></name></person-group><article-title>Genetic polymorphism in endometriosis among infertile Egyptian women</article-title><source>Middle East Fert Soc J</source><year>2002</year><volume>7</volume><fpage>44</fpage><lpage>47</lpage></element-citation></ref><ref id="DMN040C29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ertunc</surname><given-names>D</given-names></name><name><surname>Aban</surname><given-names>M</given-names></name><name><surname>Tok</surname><given-names>EC</given-names></name><name><surname>Tamer</surname><given-names>L</given-names></name><name><surname>Arslan</surname><given-names>M</given-names></name><name><surname>Dilek</surname><given-names>S</given-names></name></person-group><article-title>Glutathione-<italic>S</italic>-transferase P1 gene polymorphism and susceptibility to endometriosis</article-title><source>Hum Reprod</source><year>2005</year><volume>20</volume><fpage>2157</fpage><lpage>2161</lpage><pub-id pub-id-type="pmid">15878920</pub-id></element-citation></ref><ref id="DMN040C30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar-Morreale</surname><given-names>HF</given-names></name><name><surname>Luque-Ramirez</surname><given-names>M</given-names></name><name><surname>San Millan</surname><given-names>JL</given-names></name></person-group><article-title>The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome</article-title><source>Endocr Rev</source><year>2005</year><volume>26</volume><fpage>251</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">15561799</pub-id></element-citation></ref><ref id="DMN040C31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falconer</surname><given-names>H</given-names></name><name><surname>D&#x02019;Hooge</surname><given-names>T</given-names></name><name><surname>Fried</surname><given-names>G</given-names></name></person-group><article-title>Endometriosis and genetic polymorphisms</article-title><source>Obstet Gynecol Surv</source><year>2007</year><volume>62</volume><fpage>616</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">17705887</pub-id></element-citation></ref><ref id="DMN040C32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>RM</given-names></name><name><surname>Noval</surname><given-names>JA</given-names></name><name><surname>Garcia-Lozano</surname><given-names>JC</given-names></name><name><surname>Borrego</surname><given-names>S</given-names></name><name><surname>Molini</surname><given-names>JL</given-names></name><name><surname>Antinolo</surname><given-names>G</given-names></name></person-group><article-title>Polymorphisms in the promoter regions of FAS and FASL genes as candidate genetic factors conferring susceptibility to endometriosis</article-title><source>Int J Mol Med</source><year>2005</year><volume>15</volume><fpage>865</fpage><lpage>869</lpage><pub-id pub-id-type="pmid">15806311</pub-id></element-citation></ref><ref id="DMN040C33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>MM</given-names></name><name><surname>Biondi</surname><given-names>ML</given-names></name><name><surname>Rossi</surname><given-names>G</given-names></name><name><surname>Grijuela</surname><given-names>B</given-names></name><name><surname>Gaita</surname><given-names>S</given-names></name><name><surname>Perugino</surname><given-names>G</given-names></name><name><surname>Vigano</surname><given-names>P</given-names></name></person-group><article-title>Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis</article-title><source>Acta Obstet Gynecol Scand</source><year>2006</year><volume>85</volume><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">16532917</pub-id></element-citation></ref><ref id="DMN040C34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>PM</given-names></name><name><surname>Catarino</surname><given-names>R</given-names></name><name><surname>Pereira</surname><given-names>D</given-names></name><name><surname>Matos</surname><given-names>A</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Coelho</surname><given-names>A</given-names></name><name><surname>Lopes</surname><given-names>C</given-names></name><name><surname>Medeiros</surname><given-names>R</given-names></name></person-group><article-title>Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology</article-title><source>Eur J Clin Pharmacol</source><year>2006</year><volume>62</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16372174</pub-id></element-citation></ref><ref id="DMN040C35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgiou</surname><given-names>I</given-names></name><name><surname>Syrrou</surname><given-names>M</given-names></name><name><surname>Bouba</surname><given-names>I</given-names></name><name><surname>Dalkalitsis</surname><given-names>N</given-names></name><name><surname>Paschopoulos</surname><given-names>M</given-names></name><name><surname>Navrozoglou</surname><given-names>I</given-names></name><name><surname>Lolis</surname><given-names>D</given-names></name></person-group><article-title>Association of estrogen receptor gene polymorphisms with endometriosis</article-title><source>Fertil Steril</source><year>1999</year><volume>72</volume><fpage>164</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">10428168</pub-id></element-citation></ref><ref id="DMN040C36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goswami</surname><given-names>D</given-names></name><name><surname>Conway</surname><given-names>GS</given-names></name></person-group><article-title>Premature ovarian failure</article-title><source>Hum Reprod Update</source><year>2005</year><volume>11</volume><fpage>391</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">15919682</pub-id></element-citation></ref><ref id="DMN040C37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govindan</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>SN</given-names></name><name><surname>Vedicherla</surname><given-names>B</given-names></name><name><surname>Kodati</surname><given-names>V</given-names></name><name><surname>Jahan</surname><given-names>P</given-names></name><name><surname>Rao</surname><given-names>KP</given-names></name><name><surname>Ahuja</surname><given-names>YR</given-names></name><name><surname>Hasan</surname><given-names>Q</given-names></name></person-group><article-title>Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer</article-title><source>Cancer Biomark</source><year>2007</year><volume>3</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17522428</pub-id></element-citation></ref><ref id="DMN040C38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S-W</given-names></name></person-group><article-title>Glutathione <italic>S</italic>-transferases M1/T1 gene polymorphisms and endometriosis: A meta-analysis of genetic association studies</article-title><source>Mol Hum Reprod</source><year>2005</year><volume>11</volume><fpage>729</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">16291859</pub-id></element-citation></ref><ref id="DMN040C39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S-W</given-names></name></person-group><article-title>Association of endometriosis risk and genetic polymorphisms involving sex steroid biosynthesis and their receptors: a meta-analysis</article-title><source>Gynecol Obstet Invest</source><year>2006</year><volume>a 61</volume><fpage>90</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">16244490</pub-id></element-citation></ref><ref id="DMN040C40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S-W</given-names></name></person-group><article-title>The association of endometriosis risk and genetic polymorphisms involving dioxin detoxification enzymes: a systematic review</article-title><source>Eur J Obstet Gynecol Repro Biol</source><year>2006</year><volume>b 124</volume><fpage>134</fpage><lpage>143</lpage></element-citation></ref><ref id="DMN040C41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadfield</surname><given-names>RM</given-names></name><name><surname>Manek</surname><given-names>S</given-names></name><name><surname>Nakago</surname><given-names>S</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Mardon</surname><given-names>HJ</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name></person-group><article-title>Absence of a relationship between endometriosis and the N314D polymorphism of galactose-1-phosphate uridyl transferase in a UK population</article-title><source>Mol Hum Reprod</source><year>1999</year><volume>5</volume><fpage>990</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">10508229</pub-id></element-citation></ref><ref id="DMN040C42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadfield</surname><given-names>RM</given-names></name><name><surname>Manek</surname><given-names>S</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Mardon</surname><given-names>HJ</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name></person-group><article-title>Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1</article-title><source>Mol Hum Reprod</source><year>2001</year><volume>7</volume><fpage>1073</fpage><lpage>1078</lpage><pub-id pub-id-type="pmid">11675474</pub-id></element-citation></ref><ref id="DMN040C43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halis</surname><given-names>G</given-names></name><name><surname>Arici</surname><given-names>A</given-names></name></person-group><article-title>Endometriosis and inflammation in infertility</article-title><source>Ann N Y Acad Sci</source><year>2004</year><volume>1034</volume><fpage>300</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">15731321</pub-id></element-citation></ref><ref id="DMN040C44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name></person-group><article-title>No association of endometriosis with galactose-1-phosphate uridyl transferase mutations in a Chinese population</article-title><source>Environ Mol Mutagen</source><year>2006</year><volume>47</volume><fpage>307</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">16416427</pub-id></element-citation></ref><ref id="DMN040C45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Shi</surname><given-names>YR</given-names></name><name><surname>Tsai</surname><given-names>HD</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis</article-title><source>J Assist Reprod Genet</source><year>2001</year><volume>a 18</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">11665666</pub-id></element-citation></ref><ref id="DMN040C46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>HD</given-names></name></person-group><article-title>Androgen receptor trinucleotide polymorphism in endometriosis</article-title><source>Fertil Steril</source><year>2001</year><volume>b 76</volume><fpage>412</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">11476801</pub-id></element-citation></ref><ref id="DMN040C47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>WC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>HD</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis</article-title><source>J Clin Lab Anal</source><year>2001</year><volume>c 15</volume><fpage>184</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">11436200</pub-id></element-citation></ref><ref id="DMN040C48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Hsu</surname><given-names>Y</given-names></name><name><surname>Tsai</surname><given-names>HD</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: non-association with endometriosis</article-title><source>J Clin Lab Anal</source><year>2002</year><volume>16</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">11968047</pub-id></element-citation></ref><ref id="DMN040C49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tai</surname><given-names>CT</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name></person-group><article-title>Association of an A allele for interleukin-10 -627 gene promoter polymorphism with higher susceptibility to endometriosis</article-title><source>J Reprod Med</source><year>2003</year><volume>48</volume><fpage>735</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">14562641</pub-id></element-citation></ref><ref id="DMN040C50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>JM</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Glutathione <italic>S</italic>-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis</article-title><source>Mol Hum Reprod</source><year>2004</year><volume>a 10</volume><fpage>713</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">15299090</pub-id></element-citation></ref><ref id="DMN040C51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Cytochrome P450c17alpha 5&#x02032;-untranslated region *T/C polymorphism in endometriosis</article-title><source>J Genet</source><year>2004</year><volume>b 83</volume><fpage>189</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">15536258</pub-id></element-citation></ref><ref id="DMN040C52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Peng</surname><given-names>CT</given-names></name><name><surname>Yeh</surname><given-names>LS</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>Insulin-like growth factor II gene Apa I polymorphism is not associated with endometriosis susceptibility</article-title><source>Genet Mol Biol</source><year>2004</year><volume>c 27</volume><fpage>165</fpage><lpage>166</lpage></element-citation></ref><ref id="DMN040C53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Yeh</surname><given-names>LS</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Peng</surname><given-names>CT</given-names></name></person-group><article-title>T allele for VEGF gene-460 polymorphism at the 5&#x02032;-untranslated region: association with a higher susceptibility to endometriosis</article-title><source>J Reprod Med</source><year>2004</year><volume>d 49</volume><fpage>468</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">15283056</pub-id></element-citation></ref><ref id="DMN040C54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Hsu</surname><given-names>CM</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Angiotensin I-converting enzyme ACE 2350*G and ACE-240*T-related genotypes and alleles are associated with higher susceptibility to endometriosis</article-title><source>Mol Hum Reprod</source><year>2005</year><volume>a 11</volume><fpage>11</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15531592</pub-id></element-citation></ref><ref id="DMN040C55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Hsu</surname><given-names>CM</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Interleukin-2 receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis</article-title><source>Fertil Steril</source><year>2005</year><volume>b 84</volume><fpage>510</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">16084898</pub-id></element-citation></ref><ref id="DMN040C56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Hsu</surname><given-names>CM</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>The cuttable C-related genotype and allele for the E-cadherin 3&#x02032;-UTR Pm/l polymorphism are associated with higher susceptibility to endometriosis</article-title><source>Genet Mol Biol</source><year>2005</year><volume>c 28</volume><fpage>661</fpage><lpage>664</lpage></element-citation></ref><ref id="DMN040C57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Estrogen receptor alpha dinucleotide repeat and cytochrome P450c17alpha gene polymorphisms are associated with susceptibility to endometriosis</article-title><source>Fertil Steril</source><year>2005</year><volume>d 83</volume><fpage>567</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">15749482</pub-id></element-citation></ref><ref id="DMN040C58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas</article-title><source>Fertil Steril</source><year>2005</year><volume>e 83</volume><fpage>796</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">15749523</pub-id></element-citation></ref><ref id="DMN040C59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Peng</surname><given-names>CT</given-names></name><name><surname>Yeh</surname><given-names>LS</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>Polymorphism for transforming growth factor beta 1-509 (TGF-B1-509): association with endometriosis</article-title><source>Biochem Genet</source><year>2005</year><volume>f 43</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">16144297</pub-id></element-citation></ref><ref id="DMN040C60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name></person-group><article-title>P53 codon 11, 72, and 248 gene polymorphisms in endometriosis</article-title><source>Int J Biol Sci</source><year>2006</year><volume>2</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">16896365</pub-id></element-citation></ref><ref id="DMN040C61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Wang</surname><given-names>YK</given-names></name><name><surname>Yeh</surname><given-names>LS</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name></person-group><article-title>Angiotensin I-converting enzyme insertion-related genotypes and allele are associated with higher susceptibility of endometriosis and leiomyoma</article-title><source>Mol Reprod Dev</source><year>2007</year><volume>a 74</volume><fpage>808</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">17186537</pub-id></element-citation></ref><ref id="DMN040C62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>YK</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name></person-group><article-title>Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma</article-title><source>Mol Hum Reprod</source><year>2007</year><volume>b 13</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">17121748</pub-id></element-citation></ref><ref id="DMN040C63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>A</given-names></name><name><surname>Keck</surname><given-names>CC</given-names></name><name><surname>Hefler</surname><given-names>LA</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>JC</given-names></name><name><surname>Bentz</surname><given-names>EK</given-names></name><name><surname>Tempfer</surname><given-names>CB</given-names></name></person-group><article-title>Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions</article-title><source>Obstet Gynecol</source><year>2005</year><volume>106</volume><fpage>1025</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">16260521</pub-id></element-citation></ref><ref id="DMN040C64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>SE</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Moon</surname><given-names>HS</given-names></name><name><surname>Chung</surname><given-names>HW</given-names></name></person-group><article-title>Polymorphisms of the genes encoding the GSTM1, GSTT1 and GSTP1 in Korean women: no association with endometriosis</article-title><source>Mol Hum Reprod</source><year>2005</year><volume>11</volume><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">15531593</pub-id></element-citation></ref><ref id="DMN040C65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iizuka</surname><given-names>S</given-names></name><name><surname>Kosugi</surname><given-names>Y</given-names></name><name><surname>Isaka</surname><given-names>K</given-names></name><name><surname>Takayama</surname><given-names>M</given-names></name></person-group><article-title>Could polymorphisms of <italic>N</italic>-acetyltransferase 2 (NAT2), glutathione <italic>S</italic>-transferase M1 (GSTM1), and cytochrome P450 (CYP1A1) be responsible for genetic predisposition to endometriosis among Japanese?</article-title><source>J Tokyo Med Univ</source><year>2003</year><volume>61</volume><fpage>59</fpage><lpage>66</lpage></element-citation></ref><ref id="DMN040C66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Takakuwa</surname><given-names>K</given-names></name><name><surname>Mitsui</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name></person-group><article-title>Studies on the human leukocyte antigen-DR in patients with endometriosis: genotyping of HLA-DRB1 alleles</article-title><source>Hum Reprod</source><year>2002</year><volume>17</volume><fpage>560</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">11870103</pub-id></element-citation></ref><ref id="DMN040C67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Takakuwa</surname><given-names>K</given-names></name><name><surname>Kashima</surname><given-names>K</given-names></name><name><surname>Tamura</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name></person-group><article-title>Associations between patients with endometriosis and HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes</article-title><source>Hum Reprod</source><year>2003</year><volume>18</volume><fpage>985</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">12721173</pub-id></element-citation></ref><ref id="DMN040C68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iskhakova</surname><given-names>GMA</given-names></name></person-group><article-title>Polymorphism of the arylamine-<italic>N</italic>-acetyltransferase gene in endometriosis patients in the Republic of Bashkortostan</article-title><source>Balkan J Med Genet</source><year>2006</year><volume>9</volume><fpage>55</fpage><lpage>60</lpage></element-citation></ref><ref id="DMN040C69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivashchenko</surname><given-names>TE</given-names></name><name><surname>Shved</surname><given-names>NI</given-names></name><name><surname>Kramareva</surname><given-names>NA</given-names></name><name><surname>Ailamazian</surname><given-names>EK</given-names></name><name><surname>Baranov</surname><given-names>VS</given-names></name></person-group><article-title>Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis</article-title><source>Genetika</source><year>2003</year><volume>39</volume><fpage>525</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">12760253</pub-id></element-citation></ref><ref id="DMN040C70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juo</surname><given-names>SH</given-names></name><name><surname>Wang</surname><given-names>TN</given-names></name><name><surname>Lee</surname><given-names>JN</given-names></name><name><surname>Wu</surname><given-names>MT</given-names></name><name><surname>Long</surname><given-names>CY</given-names></name><name><surname>Tsai</surname><given-names>EM</given-names></name></person-group><article-title>CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women</article-title><source>Hum Reprod</source><year>2006</year><volume>21</volume><fpage>1498</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">16527884</pub-id></element-citation></ref><ref id="DMN040C71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kado</surname><given-names>N</given-names></name><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Ishihara</surname><given-names>H</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Kusuki</surname><given-names>I</given-names></name><name><surname>Tsukamoto</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>G</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women</article-title><source>Hum Reprod</source><year>2002</year><volume>17</volume><fpage>897</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">11925378</pub-id></element-citation></ref><ref id="DMN040C72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>JH</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>SM</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><year>2005</year><volume>40</volume><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">16202315</pub-id></element-citation></ref><ref id="DMN040C73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Bennett</surname><given-names>S</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name></person-group><article-title>Affected sib-pair analysis in endometriosis</article-title><source>Hum Reprod Update</source><year>2001</year><volume>7</volume><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">11476354</pub-id></element-citation></ref><ref id="DMN040C74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Ku</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Moon</surname><given-names>SY</given-names></name></person-group><article-title>Association between human alpha 2-Heremans Schmidt glycoprotein (AHSG) polymorphism and endometriosis in Korean women</article-title><source>Fertil Steril</source><year>2004</year><volume>82</volume><fpage>1497</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">15589849</pub-id></element-citation></ref><ref id="DMN040C75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Choung</surname><given-names>SH</given-names></name><name><surname>Jun</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Moon</surname><given-names>SY</given-names></name></person-group><article-title>Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis</article-title><source>Hum Reprod</source><year>2005</year><volume>a 20</volume><fpage>2904</fpage><lpage>2908</lpage><pub-id pub-id-type="pmid">15979997</pub-id></element-citation></ref><ref id="DMN040C76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Jun</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Moon</surname><given-names>SY</given-names></name></person-group><article-title>Estrogen receptor dinucleotide repeat polymorphism is associated with minimal or mild endometriosis</article-title><source>Fertil Steril</source><year>2005</year><volume>b 84</volume><fpage>774</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">16169423</pub-id></element-citation></ref><ref id="DMN040C77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Jee</surname><given-names>BC</given-names></name><name><surname>Suh</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name></person-group><article-title>Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women</article-title><source>Fertil Steril</source><year>2007</year><volume>a 89</volume><fpage>243</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">17482599</pub-id></element-citation></ref><ref id="DMN040C78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>GH</given-names></name><name><surname>Hong</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Moon</surname><given-names>SY</given-names></name></person-group><article-title>Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-<italic>S</italic>-transferase T1 genes</article-title><source>Hum Reprod</source><year>2007</year><volume>b 22</volume><fpage>1866</fpage><lpage>1870</lpage><pub-id pub-id-type="pmid">17513317</pub-id></element-citation></ref><ref id="DMN040C79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Ishihara</surname><given-names>H</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Kusuki</surname><given-names>I</given-names></name><name><surname>Kado</surname><given-names>N</given-names></name><name><surname>Tsukamoto</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>G</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Honjo</surname><given-names>H</given-names></name></person-group><article-title>Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata</article-title><source>Hum Reprod</source><year>2001</year><volume>16</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">11139535</pub-id></element-citation></ref><ref id="DMN040C80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Kado</surname><given-names>N</given-names></name><name><surname>Ishihara</surname><given-names>H</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Kusuki</surname><given-names>I</given-names></name><name><surname>Tsukamoto</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>G</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><etal/></person-group><article-title>Genetic contribution of the interleukin-10 promoter polymorphism in endometriosis susceptibility</article-title><source>Am J Reprod Immunol</source><year>2002</year><volume>47</volume><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">11883743</pub-id></element-citation></ref><ref id="DMN040C81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Kitaoka</surname><given-names>Y</given-names></name><name><surname>Teramoto</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>G</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Honjo</surname><given-names>H</given-names></name></person-group><article-title>Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis</article-title><source>Hum Reprod</source><year>2004</year><volume>19</volume><fpage>1765</fpage><lpage>1769</lpage><pub-id pub-id-type="pmid">15166131</pub-id></element-citation></ref><ref id="DMN040C82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Kiyomizu</surname><given-names>M</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Ishihara</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>G</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Honjo</surname><given-names>H</given-names></name></person-group><article-title>Synergistic effect of interleukin-6 promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women</article-title><source>Am J Reprod Immunol</source><year>2006</year><volume>56</volume><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">16938116</pub-id></element-citation></ref><ref id="DMN040C83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyomizu</surname><given-names>M</given-names></name><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Ishihara</surname><given-names>H</given-names></name><name><surname>Honjo</surname><given-names>H</given-names></name></person-group><article-title>Association of two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene with adenomyosis, endometriosis, and leiomyomata in Japanese women</article-title><source>J Soc Gynecol Investig</source><year>2006</year><volume>13</volume><fpage>372</fpage><lpage>377</lpage></element-citation></ref><ref id="DMN040C84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattuada</surname><given-names>D</given-names></name><name><surname>Somigliana</surname><given-names>E</given-names></name><name><surname>Vigano</surname><given-names>P</given-names></name><name><surname>Candiani</surname><given-names>M</given-names></name><name><surname>Pardi</surname><given-names>G</given-names></name><name><surname>Di Blasio</surname><given-names>AM</given-names></name></person-group><article-title>Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?</article-title><source>Clin Endocrinol (Oxf)</source><year>2004</year><volume>a 61</volume><fpage>190</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">15272913</pub-id></element-citation></ref><ref id="DMN040C85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattuada</surname><given-names>D</given-names></name><name><surname>Vigano</surname><given-names>P</given-names></name><name><surname>Somigliana</surname><given-names>E</given-names></name><name><surname>Abbiati</surname><given-names>A</given-names></name><name><surname>Candiani</surname><given-names>M</given-names></name><name><surname>Di Blasio</surname><given-names>AM</given-names></name></person-group><article-title>Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis</article-title><source>Mol Hum Reprod</source><year>2004</year><volume>b 10</volume><fpage>651</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">15273281</pub-id></element-citation></ref><ref id="DMN040C86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattuada</surname><given-names>D</given-names></name><name><surname>Vigano</surname><given-names>P</given-names></name><name><surname>Somigliana</surname><given-names>E</given-names></name><name><surname>Odorizzi</surname><given-names>MP</given-names></name><name><surname>Vignali</surname><given-names>M</given-names></name><name><surname>Di Blasio</surname><given-names>AM</given-names></name></person-group><article-title>Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis</article-title><source>J Soc Gynecol Investig</source><year>2004</year><volume>c 11</volume><fpage>237</fpage><lpage>240</lpage></element-citation></ref><ref id="DMN040C87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Layman</surname><given-names>LC</given-names></name></person-group><article-title>Editorial: BMP15&#x02014;the first true ovarian determinant gene on the X-chromosome?</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>1673</fpage><lpage>1676</lpage><pub-id pub-id-type="pmid">16679512</pub-id></element-citation></ref><ref id="DMN040C88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Park</surname><given-names>AJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><article-title>Tumor necrosis factor-alpha and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosis</article-title><source>Fertil Steril</source><year>2002</year><volume>77</volume><fpage>1304</fpage><lpage>1305</lpage><pub-id pub-id-type="pmid">12057750</pub-id></element-citation></ref><ref id="DMN040C89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>GH</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Suh</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Moon</surname><given-names>SY</given-names></name></person-group><article-title>Estrogen receptor beta gene +1730 G/A polymorphism in women with endometriosis</article-title><source>Fertil Steril</source><year>2007</year><volume>88</volume><fpage>785</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">17336962</pub-id></element-citation></ref><ref id="DMN040C90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levanat</surname><given-names>S</given-names></name><name><surname>Musani</surname><given-names>V</given-names></name><name><surname>Komar</surname><given-names>A</given-names></name><name><surname>Oreskovic</surname><given-names>S</given-names></name></person-group><article-title>Role of the hedgehog/patched signaling pathway in oncogenesis: a new polymorphism in the PTCH gene in ovarian fibroma</article-title><source>Ann N Y Acad Sci</source><year>2004</year><volume>1030</volume><fpage>134</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">15659790</pub-id></element-citation></ref><ref id="DMN040C91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohmueller</surname><given-names>KE</given-names></name><name><surname>Pearce</surname><given-names>CL</given-names></name><name><surname>Pike</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name></person-group><article-title>Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease</article-title><source>Nat Genet</source><year>2003</year><volume>33</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">12524541</pub-id></element-citation></ref><ref id="DMN040C92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luisi</surname><given-names>S</given-names></name><name><surname>Galleri</surname><given-names>L</given-names></name><name><surname>Marini</surname><given-names>F</given-names></name><name><surname>Ambrosini</surname><given-names>G</given-names></name><name><surname>Brandi</surname><given-names>ML</given-names></name><name><surname>Petraglia</surname><given-names>F</given-names></name></person-group><article-title>Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis</article-title><source>Fertil Steril</source><year>2006</year><volume>85</volume><fpage>764</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">16500359</pub-id></element-citation></ref><ref id="DMN040C93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>HB</given-names></name><name><surname>Shen</surname><given-names>DX</given-names></name><name><surname>Zong</surname><given-names>LL</given-names></name><name><surname>Guan</surname><given-names>T</given-names></name></person-group><article-title>Association of tumor necrosis factors-beta gene polymorphism with endometriosis in women in Guangdong Province</article-title><source>Nan Fang Yi Ke Da Xue Xue Bao</source><year>2006</year><volume>26</volume><fpage>1163</fpage><lpage>1165</lpage><pub-id pub-id-type="pmid">16939911</pub-id></element-citation></ref><ref id="DMN040C94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modugno</surname><given-names>F</given-names></name></person-group><article-title>Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review</article-title><source>Am J Epidemiol</source><year>2004</year><volume>159</volume><fpage>319</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">14769635</pub-id></element-citation></ref><ref id="DMN040C95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morizane</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Nakago</surname><given-names>S</given-names></name><name><surname>Hamana</surname><given-names>S</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name></person-group><article-title>No association of endometriosis with glutathione <italic>S</italic>-transferase M1 and T1 null mutations in a Japanese population</article-title><source>J Soc Gynecol Investig</source><year>2004</year><volume>11</volume><fpage>118</fpage><lpage>121</lpage></element-citation></ref><ref id="DMN040C96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morland</surname><given-names>SJ</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Hitchcock</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>EJ</given-names></name><name><surname>Campbell</surname><given-names>IG</given-names></name></person-group><article-title>Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis</article-title><source>Int J Cancer</source><year>1998</year><volume>77</volume><fpage>825</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">9714048</pub-id></element-citation></ref><ref id="DMN040C97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakago</surname><given-names>S</given-names></name><name><surname>Hadfield</surname><given-names>RM</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Mardon</surname><given-names>H</given-names></name><name><surname>Manek</surname><given-names>S</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Barlow</surname><given-names>D</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name></person-group><article-title>Association between endometriosis and <italic>N</italic>-acetyl transferase 2 polymorphisms in a UK population</article-title><source>Mol Hum Reprod</source><year>2001</year><volume>7</volume><fpage>1079</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">11675475</pub-id></element-citation></ref><ref id="DMN040C98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name><name><surname>Negoro</surname><given-names>K</given-names></name><name><surname>Hamana</surname><given-names>S</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population</article-title><source>J Soc Gynecol Investig</source><year>2004</year><volume>11</volume><fpage>232</fpage><lpage>236</lpage></element-citation></ref><ref id="DMN040C99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>DX</given-names></name><name><surname>He</surname><given-names>YL</given-names></name><name><surname>Qiu</surname><given-names>LW</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>JM</given-names></name></person-group><article-title>Susceptibility to endometriosis in women of Han Nationality in Guangdong Province associated with Msp I polymorphisms of cytochrome P450 1A1 gene</article-title><source>Di Yi Jun Yi Da Xue Xue Bao</source><year>2002</year><volume>22</volume><fpage>814</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">12297440</pub-id></element-citation></ref><ref id="DMN040C100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>DX</given-names></name><name><surname>He</surname><given-names>YL</given-names></name><name><surname>Qiu</surname><given-names>LW</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>JM</given-names></name></person-group><article-title>Association between gene mutation of cytochrome P450 1A1 in exon 7 A4889G locus and susceptibility to endometriosis</article-title><source>Chin J Med Genet</source><year>2003</year><volume>a 20</volume><fpage>284</fpage><lpage>286</lpage></element-citation></ref><ref id="DMN040C101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>DX</given-names></name><name><surname>He</surname><given-names>YL</given-names></name><name><surname>Qiu</surname><given-names>LW</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>JM</given-names></name></person-group><article-title>Association between glutathione <italic>S</italic>-transferase M1 gene deletion and genetic susceptibility to endometriosis</article-title><source>Di Yi Jun Yi Da Xue Xue Bao</source><year>2003</year><volume>b 23</volume><fpage>458</fpage><lpage>459</lpage><comment>462</comment><pub-id pub-id-type="pmid">12754129</pub-id></element-citation></ref><ref id="DMN040C102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pritts</surname><given-names>EA</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Ricke</surname><given-names>E</given-names></name><name><surname>Waite</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>RN</given-names></name></person-group><article-title>PPAR-gamma decreases endometrial stromal cell transcription and translation of RANTES <italic>in vitro</italic></article-title><source>J Clin Endocrinol Metab</source><year>2002</year><volume>87</volume><fpage>1841</fpage><lpage>1844</lpage><pub-id pub-id-type="pmid">11932328</pub-id></element-citation></ref><ref id="DMN040C103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>SP</given-names></name><name><surname>Strick</surname><given-names>R</given-names></name><name><surname>Oppelt</surname><given-names>P</given-names></name><name><surname>Fasching</surname><given-names>PA</given-names></name><name><surname>Engel</surname><given-names>S</given-names></name><name><surname>Baumann</surname><given-names>R</given-names></name><name><surname>Beckmann</surname><given-names>MW</given-names></name><name><surname>Strissel</surname><given-names>PL</given-names></name></person-group><article-title>Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis</article-title><source>Reproduction</source><year>2006</year><volume>131</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">16388018</pub-id></element-citation></ref><ref id="DMN040C104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>K</given-names></name><name><surname>Ying</surname><given-names>W</given-names></name><name><surname>Jian-Hui</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Na</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name></person-group><article-title>The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China</article-title><source>Mol Hum Reprod</source><year>2005</year><volume>11</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">15879464</pub-id></element-citation></ref><ref id="DMN040C105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>K</given-names></name><name><surname>Lian-Fu</surname><given-names>Z</given-names></name><name><surname>Hui</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Na</surname><given-names>W</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name></person-group><article-title>Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China</article-title><source>Mol Hum Reprod</source><year>2006</year><volume>12</volume><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">16455621</pub-id></element-citation></ref><ref id="DMN040C106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>K</given-names></name><name><surname>Xiao-Wei</surname><given-names>M</given-names></name><name><surname>Na</surname><given-names>W</given-names></name><name><surname>Xiu-Feng</surname><given-names>Z</given-names></name><name><surname>ng-Gui</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Zheng-Mao</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name></person-group><article-title>Association of three single nucleotide polymorphisms of the E-cadherin gene with endometriosis in a Chinese population</article-title><source>Reproduction</source><year>2007</year><volume>134</volume><fpage>373</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">17660246</pub-id></element-citation></ref><ref id="DMN040C107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Geirsson</surname><given-names>RT</given-names></name><name><surname>Guanason</surname><given-names>GA</given-names></name></person-group><article-title>A genome-wide search for endometriosis in Icelandic patients</article-title><source>Am J Hum Genet</source><year>1998</year><volume>63</volume><fpage>A310</fpage></element-citation></ref><ref id="DMN040C108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Einarsdottir</surname><given-names>A</given-names></name><name><surname>Geirsson</surname><given-names>RT</given-names></name><name><surname>Jonsdottir</surname><given-names>K</given-names></name><name><surname>Sverrisdottir</surname><given-names>G</given-names></name><name><surname>Gudnadottir</surname><given-names>VG</given-names></name><name><surname>Gunnarsdottir</surname><given-names>S</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><name><surname>Gulcher</surname><given-names>J</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>Endometriosis is not associated with or linked to the GALT gene</article-title><source>Fertil Steril</source><year>2001</year><volume>76</volume><fpage>1019</fpage><lpage>1022</lpage><pub-id pub-id-type="pmid">11704127</pub-id></element-citation></ref><ref id="DMN040C109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tempfer</surname><given-names>CB</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>JC</given-names></name></person-group><article-title>Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology</article-title><source>Pharmacogenomics</source><year>2004</year><volume>5</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">14683420</pub-id></element-citation></ref><ref id="DMN040C110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tempfer</surname><given-names>CB</given-names></name><name><surname>Riener</surname><given-names>EK</given-names></name><name><surname>Keck</surname><given-names>C</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name><name><surname>Heinze</surname><given-names>G</given-names></name><name><surname>Huber</surname><given-names>JC</given-names></name><name><surname>Gitsch</surname><given-names>G</given-names></name><name><surname>Hefler</surname><given-names>LA</given-names></name></person-group><article-title>Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women</article-title><source>Menopause</source><year>2005</year><volume>12</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">15879922</pub-id></element-citation></ref><ref id="DMN040C111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teramoto</surname><given-names>M</given-names></name><name><surname>Kitawaki</surname><given-names>J</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Kitaoka</surname><given-names>Y</given-names></name><name><surname>Obayashi</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>G</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Maruya</surname><given-names>E</given-names></name><etal/></person-group><article-title>Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility</article-title><source>Am J Reprod Immunol</source><year>2004</year><volume>51</volume><fpage>352</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">15212671</pub-id></element-citation></ref><ref id="DMN040C112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>DT</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>VM</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name></person-group><article-title>Genetic influences on endometriosis in an Australian twin sample</article-title><source>Fertil Steril</source><year>1999</year><volume>71</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">10202882</pub-id></element-citation></ref><ref id="DMN040C113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Bahlo</surname><given-names>M</given-names></name><name><surname>Ewen</surname><given-names>K</given-names></name></person-group><article-title>Suggestive linkage for endometriosis found in genome-wide scan</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><fpage>727</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">10924406</pub-id></element-citation></ref><ref id="DMN040C114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Armitage</surname><given-names>T</given-names></name><name><surname>Duffy</surname><given-names>DL</given-names></name><name><surname>Wicks</surname><given-names>J</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>DT</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name></person-group><article-title>Association between polymorphisms in the progesterone receptor gene and endometriosis</article-title><source>Mol Hum Reprod</source><year>2005</year><volume>a 11</volume><fpage>641</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">16126772</pub-id></element-citation></ref><ref id="DMN040C115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Wicks</surname><given-names>J</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Bahlo</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>V</given-names></name><etal/></person-group><article-title>Genomwide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26</article-title><source>Am J Hum Genet</source><year>2005</year><volume>b 77</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">16080113</pub-id></element-citation></ref><ref id="DMN040C116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Le</surname><given-names>L</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name></person-group><article-title>Variants in EMX2 and PTEN do not contribute to risk of endometriosis</article-title><source>Mol Hum Reprod</source><year>2007</year><volume>13</volume><fpage>587</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">17563403</pub-id></element-citation></ref><ref id="DMN040C117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>M</given-names></name><name><surname>Katoh</surname><given-names>T</given-names></name><name><surname>Motoyama</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name><name><surname>Ikenoue</surname><given-names>T</given-names></name></person-group><article-title>Analysis of the AhR, ARNT, and AhRR gene polymorphisms: genetic contribution to endometriosis susceptibility and severity</article-title><source>Fertil Steril</source><year>2005</year><volume>a 84</volume><fpage>454</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">16084889</pub-id></element-citation></ref><ref id="DMN040C118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>M</given-names></name><name><surname>Nakao</surname><given-names>H</given-names></name><name><surname>Katoh</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Hiroshima</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Matsunaga</surname><given-names>T</given-names></name><name><surname>Hanaoka</surname><given-names>T</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name><name><surname>Ikenoue</surname><given-names>T</given-names></name></person-group><article-title>Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19</article-title><source>Hum Reprod</source><year>2005</year><volume>b 20</volume><fpage>974</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">15640252</pub-id></element-citation></ref><ref id="DMN040C119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kaam</surname><given-names>KJ</given-names></name><name><surname>Romano</surname><given-names>A</given-names></name><name><surname>Dunselman</surname><given-names>GA</given-names></name><name><surname>Groothuis</surname><given-names>PG</given-names></name></person-group><article-title>Transforming growth factor beta1 gene polymorphism 509C/T in deep infiltrating endometriosis</article-title><source>Reprod Sci</source><year>2007</year><volume>a 14</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">17644809</pub-id></element-citation></ref><ref id="DMN040C120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kaam</surname><given-names>KJ</given-names></name><name><surname>Romano</surname><given-names>A</given-names></name><name><surname>Schouten</surname><given-names>JP</given-names></name><name><surname>Dunselman</surname><given-names>GA</given-names></name><name><surname>Groothuis</surname><given-names>PG</given-names></name></person-group><article-title>Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis</article-title><source>Hum Reprod</source><year>2007</year><volume>b 22</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">16920727</pub-id></element-citation></ref><ref id="DMN040C121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vietri</surname><given-names>MT</given-names></name><name><surname>Molinari</surname><given-names>AM</given-names></name><name><surname>Iannella</surname><given-names>I</given-names></name><name><surname>Cioffi</surname><given-names>M</given-names></name><name><surname>Bontempo</surname><given-names>P</given-names></name><name><surname>Ardovino</surname><given-names>M</given-names></name><name><surname>Scaffa</surname><given-names>C</given-names></name><name><surname>Colacurci</surname><given-names>N</given-names></name><name><surname>Cobellis</surname><given-names>L</given-names></name></person-group><article-title>Arg72Pro p53 polymorphism in Italian women: no association with endometriosis</article-title><source>Fertil Steril</source><year>2007</year><volume>88</volume><fpage>1468</fpage><lpage>1469</lpage><pub-id pub-id-type="pmid">17412337</pub-id></element-citation></ref><ref id="DMN040C122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigano</surname><given-names>P</given-names></name><name><surname>Infantino</surname><given-names>M</given-names></name><name><surname>Lattuada</surname><given-names>D</given-names></name><name><surname>Lauletta</surname><given-names>R</given-names></name><name><surname>Ponti</surname><given-names>E</given-names></name><name><surname>Somigliana</surname><given-names>E</given-names></name><name><surname>Vignali</surname><given-names>M</given-names></name><name><surname>DiBlasio</surname><given-names>AM</given-names></name></person-group><article-title>Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis</article-title><source>Mol Hum Reprod</source><year>2003</year><volume>9</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">12529420</pub-id></element-citation></ref><ref id="DMN040C123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigano</surname><given-names>P</given-names></name><name><surname>Lattuada</surname><given-names>D</given-names></name><name><surname>Somigliana</surname><given-names>E</given-names></name><name><surname>Abbiati</surname><given-names>A</given-names></name><name><surname>Candiani</surname><given-names>M</given-names></name><name><surname>Di Blasio</surname><given-names>AM</given-names></name></person-group><article-title>Variants of the CTLA4 gene that segregate with autoimmune diseases are not associated with endometriosis</article-title><source>Mol Hum Reprod</source><year>2005</year><volume>11</volume><fpage>745</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">16373368</pub-id></element-citation></ref><ref id="DMN040C124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigano</surname><given-names>P</given-names></name><name><surname>Somigliana</surname><given-names>E</given-names></name><name><surname>Vignali</surname><given-names>M</given-names></name><name><surname>Busacca</surname><given-names>M</given-names></name><name><surname>Blasio</surname><given-names>AM</given-names></name></person-group><article-title>Genetics of endometriosis: current status and prospects</article-title><source>Front Biosci</source><year>2007</year><volume>12</volume><fpage>3247</fpage><lpage>3255</lpage><pub-id pub-id-type="pmid">17485295</pub-id></element-citation></ref><ref id="DMN040C125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name></person-group><article-title>Study on polymorphism of human leukocyte antigen I in patients with endometriosis</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><year>2001</year><volume>36</volume><fpage>150</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">11783390</pub-id></element-citation></ref><ref id="DMN040C126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Mei</surname><given-names>Q</given-names></name></person-group><article-title>Study on polymorphism of human leukocyte antigen-DRB1 allele in patients with endometriosis</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><year>2002</year><volume>37</volume><fpage>346</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">12126569</pub-id></element-citation></ref><ref id="DMN040C127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Negoro</surname><given-names>K</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Barlow</surname><given-names>D</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population</article-title><source>Fertil Steril</source><year>2004</year><volume>81</volume><fpage>1650</fpage><lpage>1656</lpage><pub-id pub-id-type="pmid">15193490</pub-id></element-citation></ref><ref id="DMN040C128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Imoto</surname><given-names>I</given-names></name><name><surname>Kosugi</surname><given-names>Y</given-names></name><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Mimura</surname><given-names>J</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Isaka</surname><given-names>K</given-names></name><name><surname>Takayama</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Inazawa</surname><given-names>J</given-names></name></person-group><article-title>Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis</article-title><source>J Hum Genet</source><year>2001</year><volume>46</volume><fpage>342</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">11393538</pub-id></element-citation></ref><ref id="DMN040C129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name></person-group><article-title>Research on relationship between gene polymorphisms of interleukin-1 family and endometriosis</article-title><source>Zhejiang Da Xue Xue Bao Yi Xue Ban</source><year>2006</year><volume>35</volume><fpage>653</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">17177339</pub-id></element-citation></ref><ref id="DMN040C130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzl</surname><given-names>R</given-names></name><name><surname>Kiesel</surname><given-names>L</given-names></name><name><surname>Huber</surname><given-names>JC</given-names></name><name><surname>Wieser</surname><given-names>F</given-names></name></person-group><article-title>Endometriosis: a genetic disease</article-title><source>Drugs Today (Barc)</source><year>2003</year><volume>39</volume><fpage>961</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">14747841</pub-id></element-citation></ref><ref id="DMN040C131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whang</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Noh</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>YB</given-names></name></person-group><article-title>No association between HLA-DRB1 alleles and susceptibility to advanced stage endometriosis in a Korean population</article-title><source>Hum Reprod</source><year>2006</year><volume>21</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">16155070</pub-id></element-citation></ref><ref id="DMN040C132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>F</given-names></name><name><surname>Fabjani</surname><given-names>G</given-names></name><name><surname>Tempfer</surname><given-names>C</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name><name><surname>Zeillinger</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>JC</given-names></name><name><surname>Wenzl</surname><given-names>R</given-names></name></person-group><article-title>Tumor necrosis factor-alpha promotor polymorphisms and endometriosis</article-title><source>J Soc Gynecol Investig</source><year>2002</year><volume>a 9</volume><fpage>313</fpage><lpage>318</lpage></element-citation></ref><ref id="DMN040C133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>F</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name><name><surname>Tong</surname><given-names>D</given-names></name><name><surname>Tempfer</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>JC</given-names></name><name><surname>Wenzl</surname><given-names>R</given-names></name></person-group><article-title>PROGINS receptor gene polymorphism is associated with endometriosis</article-title><source>Fertil Steril</source><year>2002</year><volume>b 77</volume><fpage>309</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">11821088</pub-id></element-citation></ref><ref id="DMN040C134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>F</given-names></name><name><surname>Wenzl</surname><given-names>R</given-names></name><name><surname>Tempfer</surname><given-names>C</given-names></name><name><surname>Worda</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>J</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name></person-group><article-title>Catechol-<italic>O</italic>-methyltransferase polymorphism and endometriosis</article-title><source>J Assist Reprod Genet</source><year>2002</year><volume>c 19</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">12168735</pub-id></element-citation></ref><ref id="DMN040C135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>F</given-names></name><name><surname>Fabjani</surname><given-names>G</given-names></name><name><surname>Tempfer</surname><given-names>C</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name><name><surname>Sator</surname><given-names>M</given-names></name><name><surname>Huber</surname><given-names>J</given-names></name><name><surname>Wenzl</surname><given-names>R</given-names></name></person-group><article-title>Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing</article-title><source>J Soc Gynecol Investig</source><year>2003</year><volume>a 10</volume><fpage>32</fpage><lpage>36</lpage></element-citation></ref><ref id="DMN040C136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>F</given-names></name><name><surname>Hefler</surname><given-names>L</given-names></name><name><surname>Tempfer</surname><given-names>C</given-names></name><name><surname>Vlach</surname><given-names>U</given-names></name><name><surname>Schneeberger</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>J</given-names></name><name><surname>Wenzl</surname><given-names>R</given-names></name></person-group><article-title>Polymorphism of the interleukin-1beta gene and endometriosis</article-title><source>J Soc Gynecol Investig</source><year>2003</year><volume>b 10</volume><fpage>172</fpage><lpage>175</lpage></element-citation></ref><ref id="DMN040C137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>MY</given-names></name><name><surname>Chao</surname><given-names>KH</given-names></name><name><surname>Yang</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Yang</surname><given-names>YS</given-names></name><name><surname>Ho</surname><given-names>HN</given-names></name></person-group><article-title>Nitric oxide synthesis is increased in the endometrial tissue of women with endometriosis</article-title><source>Hum Reprod</source><year>2003</year><volume>18</volume><fpage>2668</fpage><lpage>2671</lpage><pub-id pub-id-type="pmid">14645189</pub-id></element-citation></ref><ref id="DMN040C138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Ohara</surname><given-names>N</given-names></name><name><surname>Motoyama</surname><given-names>S</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>Association study of endometriosis and intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in a Japanese population</article-title><source>J Soc Gynecol Investig</source><year>2005</year><volume>12</volume><fpage>267</fpage><lpage>271</lpage></element-citation></ref><ref id="DMN040C139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zervou</surname><given-names>S</given-names></name><name><surname>Karteris</surname><given-names>E</given-names></name><name><surname>Goumenou</surname><given-names>AG</given-names></name><name><surname>Vatish</surname><given-names>M</given-names></name><name><surname>Koumantakis</surname><given-names>EE</given-names></name><name><surname>Hillhouse</surname><given-names>EW</given-names></name></person-group><article-title>The Glu298&#x02013;&#x0003e;Asp polymorphism of the endothelial nitric oxide synthase gene is associated with endometriosis</article-title><source>Fertil Steril</source><year>2003</year><volume>80</volume><fpage>1524</fpage><lpage>1525</lpage><pub-id pub-id-type="pmid">14667898</pub-id></element-citation></ref><ref id="DMN040C140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Le</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>James</surname><given-names>MR</given-names></name><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name></person-group><article-title>KRAS variation and risk of endometriosis</article-title><source>Mol Hum Reprod</source><year>2006</year><volume>12</volume><fpage>671</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">16973828</pub-id></element-citation></ref><ref id="DMN040C141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Le</surname><given-names>L</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Engwerda</surname><given-names>C</given-names></name><name><surname>Randall</surname><given-names>L</given-names></name><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name></person-group><article-title>Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample</article-title><source>Hum Reprod</source><year>2007</year><volume>22</volume><fpage>2389</fpage><lpage>2397</lpage><pub-id pub-id-type="pmid">17595314</pub-id></element-citation></ref><ref id="DMN040C142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name></person-group><article-title>What makes a good case-control study? Design issues for complex traits such as endometriosis</article-title><source>Hum Reprod</source><year>2002</year><volume>17</volume><fpage>1415</fpage><lpage>1423</lpage><pub-id pub-id-type="pmid">12042253</pub-id></element-citation></ref><ref id="DMN040C143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Mangion</surname><given-names>J</given-names></name><etal/></person-group><article-title>Significant evidence of one or more susceptibility loci for endometriosis with near-Mendelian inheritance on chromosome 7p13-15</article-title><source>Hum Reprod</source><year>2007</year><volume>22</volume><fpage>717</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">17158817</pub-id></element-citation></ref></ref-list></back></article>